Project
Inflammatory response time course, HUVEC (Wada, 2009)
Navigation
Downloads
Results for IKZF1
Z-value: 2.66
Motif logo
Transcription factors associated with IKZF1
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
IKZF1
|
ENSG00000185811.19 | IKZF1 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| IKZF1 | hg38_v1_chr7_+_50304693_50304782 | 0.67 | 2.9e-04 | Click! |
Activity profile of IKZF1 motif
Sorted Z-values of IKZF1 motif
Network of associatons between targets according to the STRING database.
First level regulatory network of IKZF1
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.1 | 12.3 | GO:0051040 | regulation of calcium-independent cell-cell adhesion(GO:0051040) |
| 3.9 | 19.4 | GO:0001315 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 3.6 | 10.8 | GO:0045062 | extrathymic T cell selection(GO:0045062) |
| 3.6 | 25.1 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 3.3 | 13.0 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
| 3.3 | 9.8 | GO:0046967 | cytosol to ER transport(GO:0046967) |
| 3.3 | 9.8 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
| 3.2 | 3.2 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) negative regulation of interleukin-12 secretion(GO:2001183) |
| 3.1 | 6.3 | GO:0002537 | nitric oxide production involved in inflammatory response(GO:0002537) |
| 2.6 | 7.9 | GO:0038156 | interleukin-3-mediated signaling pathway(GO:0038156) |
| 2.5 | 50.3 | GO:0003374 | dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
| 2.5 | 10.0 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
| 2.4 | 21.6 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
| 2.2 | 6.7 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
| 2.0 | 12.1 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
| 2.0 | 5.9 | GO:0071224 | cellular response to peptidoglycan(GO:0071224) |
| 2.0 | 17.8 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 2.0 | 5.9 | GO:0044501 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 1.9 | 5.8 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
| 1.9 | 5.8 | GO:1900161 | regulation of phospholipid scramblase activity(GO:1900161) positive regulation of phospholipid scramblase activity(GO:1900163) regulation of glucosylceramide catabolic process(GO:2000752) positive regulation of glucosylceramide catabolic process(GO:2000753) regulation of sphingomyelin catabolic process(GO:2000754) positive regulation of sphingomyelin catabolic process(GO:2000755) |
| 1.9 | 5.7 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
| 1.9 | 3.8 | GO:0032730 | positive regulation of interleukin-1 alpha production(GO:0032730) |
| 1.8 | 14.3 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 1.8 | 5.3 | GO:0045212 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
| 1.7 | 6.6 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
| 1.6 | 6.6 | GO:0033590 | response to cobalamin(GO:0033590) |
| 1.6 | 3.3 | GO:0032499 | detection of peptidoglycan(GO:0032499) |
| 1.6 | 6.4 | GO:0050822 | peptide stabilization(GO:0050822) peptide antigen stabilization(GO:0050823) |
| 1.6 | 6.3 | GO:1904116 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
| 1.6 | 3.1 | GO:0002730 | regulation of dendritic cell cytokine production(GO:0002730) |
| 1.5 | 4.4 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
| 1.5 | 5.9 | GO:0010585 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 1.5 | 5.9 | GO:0009224 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 1.5 | 5.8 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 1.4 | 4.3 | GO:0042946 | glucoside transport(GO:0042946) |
| 1.4 | 7.1 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
| 1.4 | 5.7 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
| 1.4 | 5.6 | GO:1903490 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 1.4 | 1.4 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
| 1.4 | 4.1 | GO:1901899 | positive regulation of relaxation of cardiac muscle(GO:1901899) |
| 1.3 | 3.9 | GO:0070407 | oxidation-dependent protein catabolic process(GO:0070407) |
| 1.3 | 2.6 | GO:0042704 | uterine wall breakdown(GO:0042704) |
| 1.3 | 5.2 | GO:0021836 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) |
| 1.3 | 3.9 | GO:0042495 | detection of triacyl bacterial lipopeptide(GO:0042495) detection of bacterial lipopeptide(GO:0070340) |
| 1.3 | 5.2 | GO:1904800 | negative regulation of dendrite extension(GO:1903860) regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
| 1.3 | 3.8 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
| 1.2 | 16.1 | GO:1900625 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 1.2 | 12.4 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 1.2 | 8.5 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
| 1.2 | 15.8 | GO:0046449 | creatinine metabolic process(GO:0046449) |
| 1.2 | 7.2 | GO:0060356 | leucine import(GO:0060356) |
| 1.2 | 3.6 | GO:0033025 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
| 1.1 | 4.5 | GO:1902568 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
| 1.1 | 13.4 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
| 1.1 | 5.6 | GO:0034344 | type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
| 1.1 | 4.3 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
| 1.1 | 1.1 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
| 1.1 | 3.2 | GO:0035281 | pre-miRNA export from nucleus(GO:0035281) |
| 1.0 | 4.2 | GO:0032581 | ER-dependent peroxisome organization(GO:0032581) |
| 1.0 | 4.2 | GO:0060611 | positive regulation of odontogenesis of dentin-containing tooth(GO:0042488) mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) positive regulation of microglial cell migration(GO:1904141) |
| 1.0 | 4.2 | GO:2001247 | positive regulation of phosphatidylcholine biosynthetic process(GO:2001247) |
| 1.0 | 2.0 | GO:0019249 | lactate biosynthetic process(GO:0019249) |
| 1.0 | 5.0 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 1.0 | 8.0 | GO:0006203 | dGTP catabolic process(GO:0006203) |
| 1.0 | 4.9 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
| 1.0 | 5.8 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
| 1.0 | 4.8 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
| 1.0 | 3.8 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
| 1.0 | 2.9 | GO:0016094 | polyprenol biosynthetic process(GO:0016094) |
| 0.9 | 2.8 | GO:0034147 | regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) |
| 0.9 | 10.9 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
| 0.9 | 7.2 | GO:0071351 | interleukin-18-mediated signaling pathway(GO:0035655) cellular response to interleukin-18(GO:0071351) |
| 0.9 | 2.7 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.9 | 3.6 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) |
| 0.9 | 8.8 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 0.9 | 12.3 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
| 0.9 | 2.6 | GO:1903413 | cellular response to bile acid(GO:1903413) |
| 0.9 | 2.6 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 0.9 | 6.8 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 0.9 | 7.7 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
| 0.8 | 2.5 | GO:0032912 | negative regulation of transforming growth factor beta2 production(GO:0032912) regulation of melanosome transport(GO:1902908) |
| 0.8 | 7.5 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
| 0.8 | 2.5 | GO:0014028 | notochord formation(GO:0014028) |
| 0.8 | 6.6 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.8 | 3.3 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
| 0.8 | 7.4 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
| 0.8 | 10.6 | GO:0032782 | bile acid secretion(GO:0032782) |
| 0.8 | 3.2 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
| 0.8 | 3.2 | GO:0009443 | pyridoxal 5'-phosphate salvage(GO:0009443) |
| 0.8 | 2.4 | GO:0000472 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
| 0.8 | 3.2 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.8 | 3.2 | GO:0070981 | L-asparagine biosynthetic process(GO:0070981) L-asparagine metabolic process(GO:0070982) |
| 0.8 | 6.3 | GO:0070842 | aggresome assembly(GO:0070842) |
| 0.8 | 2.3 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
| 0.8 | 4.5 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
| 0.7 | 2.2 | GO:0006579 | amino-acid betaine catabolic process(GO:0006579) |
| 0.7 | 1.5 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 0.7 | 2.9 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
| 0.7 | 2.9 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
| 0.7 | 4.3 | GO:0035617 | stress granule disassembly(GO:0035617) |
| 0.7 | 3.6 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
| 0.7 | 2.2 | GO:0044278 | cell wall disruption in other organism(GO:0044278) |
| 0.7 | 1.4 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
| 0.7 | 3.5 | GO:0043128 | regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
| 0.7 | 4.9 | GO:0030259 | lipid glycosylation(GO:0030259) |
| 0.7 | 3.5 | GO:1903936 | cellular response to sodium arsenite(GO:1903936) |
| 0.7 | 2.1 | GO:1902232 | regulation of positive thymic T cell selection(GO:1902232) |
| 0.7 | 2.8 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
| 0.7 | 8.3 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.7 | 1.4 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
| 0.7 | 2.1 | GO:0003147 | neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) |
| 0.7 | 8.2 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
| 0.7 | 16.5 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
| 0.7 | 2.7 | GO:0002215 | defense response to nematode(GO:0002215) |
| 0.7 | 2.7 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.7 | 2.7 | GO:0002268 | follicular dendritic cell differentiation(GO:0002268) |
| 0.7 | 2.7 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.7 | 4.0 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 0.7 | 1.3 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.7 | 2.0 | GO:0034769 | basement membrane disassembly(GO:0034769) |
| 0.7 | 1.3 | GO:0099543 | retrograde trans-synaptic signaling by soluble gas(GO:0098923) trans-synaptic signaling by soluble gas(GO:0099543) |
| 0.7 | 1.3 | GO:0051885 | positive regulation of anagen(GO:0051885) |
| 0.7 | 2.7 | GO:0097045 | phosphatidylserine exposure on blood platelet(GO:0097045) |
| 0.7 | 4.6 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
| 0.7 | 3.9 | GO:0007296 | vitellogenesis(GO:0007296) |
| 0.7 | 0.7 | GO:1902159 | regulation of cyclic nucleotide-gated ion channel activity(GO:1902159) |
| 0.7 | 1.3 | GO:0042940 | D-amino acid transport(GO:0042940) |
| 0.6 | 1.9 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
| 0.6 | 3.9 | GO:0061734 | parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
| 0.6 | 1.9 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.6 | 0.6 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
| 0.6 | 5.1 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
| 0.6 | 1.3 | GO:2000309 | activation of MAPK activity involved in innate immune response(GO:0035419) positive regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000309) |
| 0.6 | 3.8 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
| 0.6 | 3.7 | GO:0035803 | egg coat formation(GO:0035803) |
| 0.6 | 1.9 | GO:1903762 | positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903762) positive regulation of ventricular cardiac muscle cell action potential(GO:1903947) positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential(GO:1905026) positive regulation of membrane repolarization during cardiac muscle cell action potential(GO:1905033) |
| 0.6 | 13.0 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
| 0.6 | 3.1 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
| 0.6 | 1.8 | GO:0002339 | B cell selection(GO:0002339) |
| 0.6 | 3.1 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
| 0.6 | 1.8 | GO:1902528 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 0.6 | 1.2 | GO:1903412 | response to bile acid(GO:1903412) |
| 0.6 | 2.4 | GO:0048200 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.6 | 0.6 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
| 0.6 | 1.8 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
| 0.6 | 1.8 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
| 0.6 | 0.6 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
| 0.6 | 0.6 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
| 0.6 | 5.3 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
| 0.6 | 2.4 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.6 | 1.8 | GO:0045645 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
| 0.6 | 1.8 | GO:0061573 | endoplasmic reticulum polarization(GO:0061163) actin filament bundle retrograde transport(GO:0061573) actin filament bundle distribution(GO:0070650) |
| 0.6 | 0.6 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
| 0.6 | 17.6 | GO:2001223 | negative regulation of neuron migration(GO:2001223) |
| 0.6 | 16.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.6 | 1.7 | GO:0001983 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
| 0.6 | 1.1 | GO:0060434 | bronchus morphogenesis(GO:0060434) |
| 0.6 | 2.3 | GO:0006868 | glutamine transport(GO:0006868) |
| 0.6 | 0.6 | GO:0032627 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
| 0.6 | 3.4 | GO:0010840 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) circadian sleep/wake cycle, wakefulness(GO:0042746) |
| 0.6 | 1.7 | GO:0035048 | splicing factor protein import into nucleus(GO:0035048) |
| 0.6 | 2.3 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
| 0.6 | 0.6 | GO:0061317 | canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:0061317) |
| 0.6 | 1.1 | GO:0002543 | activation of blood coagulation via clotting cascade(GO:0002543) |
| 0.6 | 3.4 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
| 0.6 | 1.1 | GO:1901253 | negative regulation of intracellular transport of viral material(GO:1901253) |
| 0.6 | 1.7 | GO:1904640 | response to methionine(GO:1904640) |
| 0.6 | 3.9 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
| 0.6 | 1.7 | GO:0090222 | centrosome-templated microtubule nucleation(GO:0090222) |
| 0.6 | 4.4 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
| 0.5 | 4.4 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
| 0.5 | 1.6 | GO:0009720 | detection of hormone stimulus(GO:0009720) |
| 0.5 | 8.7 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.5 | 0.5 | GO:2000403 | positive regulation of lymphocyte migration(GO:2000403) |
| 0.5 | 1.6 | GO:1902524 | positive regulation of protein K48-linked ubiquitination(GO:1902524) |
| 0.5 | 0.5 | GO:0032827 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
| 0.5 | 3.7 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
| 0.5 | 8.0 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
| 0.5 | 2.1 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
| 0.5 | 2.1 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 0.5 | 1.6 | GO:1904933 | regulation of cell proliferation in midbrain(GO:1904933) |
| 0.5 | 2.7 | GO:0021764 | amygdala development(GO:0021764) |
| 0.5 | 1.1 | GO:0002876 | positive regulation of chronic inflammatory response to antigenic stimulus(GO:0002876) |
| 0.5 | 17.3 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
| 0.5 | 3.1 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
| 0.5 | 1.0 | GO:0021551 | central nervous system morphogenesis(GO:0021551) |
| 0.5 | 3.1 | GO:2000234 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.5 | 2.1 | GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling(GO:0010902) |
| 0.5 | 1.0 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
| 0.5 | 1.6 | GO:1903422 | negative regulation of synaptic vesicle recycling(GO:1903422) |
| 0.5 | 1.6 | GO:2000374 | regulation of oxygen metabolic process(GO:2000374) |
| 0.5 | 2.1 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
| 0.5 | 1.5 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
| 0.5 | 4.1 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.5 | 1.0 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
| 0.5 | 1.0 | GO:0046832 | negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
| 0.5 | 1.5 | GO:1902688 | regulation of NAD metabolic process(GO:1902688) |
| 0.5 | 1.5 | GO:0007518 | myoblast fate determination(GO:0007518) |
| 0.5 | 1.5 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
| 0.5 | 6.1 | GO:0018377 | protein myristoylation(GO:0018377) |
| 0.5 | 3.6 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
| 0.5 | 1.0 | GO:0060313 | negative regulation of blood vessel remodeling(GO:0060313) |
| 0.5 | 2.5 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
| 0.5 | 1.5 | GO:0010768 | negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010768) transmission of virus(GO:0019089) dissemination or transmission of symbiont from host(GO:0044007) dissemination or transmission of organism from other organism involved in symbiotic interaction(GO:0051821) |
| 0.5 | 7.1 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
| 0.5 | 1.0 | GO:2000848 | positive regulation of corticosteroid hormone secretion(GO:2000848) |
| 0.5 | 1.5 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
| 0.5 | 5.0 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.5 | 1.0 | GO:0071105 | response to interleukin-11(GO:0071105) |
| 0.5 | 2.0 | GO:2000681 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
| 0.5 | 7.9 | GO:0051601 | exocyst localization(GO:0051601) |
| 0.5 | 4.4 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
| 0.5 | 0.5 | GO:0009155 | purine deoxyribonucleotide catabolic process(GO:0009155) |
| 0.5 | 4.9 | GO:0086024 | adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
| 0.5 | 9.7 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
| 0.5 | 2.9 | GO:1903435 | positive regulation of constitutive secretory pathway(GO:1903435) |
| 0.5 | 4.3 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
| 0.5 | 1.4 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
| 0.5 | 1.4 | GO:1904693 | midbrain morphogenesis(GO:1904693) |
| 0.5 | 1.4 | GO:0061027 | umbilical cord morphogenesis(GO:0036304) umbilical cord development(GO:0061027) |
| 0.5 | 1.9 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
| 0.5 | 2.8 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
| 0.5 | 0.9 | GO:0050925 | negative regulation of negative chemotaxis(GO:0050925) |
| 0.5 | 2.8 | GO:0070424 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) |
| 0.5 | 7.0 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
| 0.5 | 3.3 | GO:2001171 | positive regulation of ATP biosynthetic process(GO:2001171) |
| 0.5 | 5.1 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
| 0.5 | 1.4 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
| 0.5 | 1.4 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
| 0.5 | 8.8 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
| 0.5 | 3.2 | GO:0048165 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) negative regulation of chondrocyte proliferation(GO:1902731) |
| 0.5 | 0.5 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
| 0.5 | 1.4 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
| 0.5 | 2.3 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
| 0.5 | 0.9 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
| 0.5 | 4.1 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
| 0.5 | 0.9 | GO:0072338 | cellular lactam metabolic process(GO:0072338) |
| 0.5 | 0.5 | GO:1900107 | regulation of nodal signaling pathway(GO:1900107) |
| 0.5 | 0.5 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
| 0.4 | 1.3 | GO:1901535 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
| 0.4 | 0.9 | GO:0045819 | positive regulation of glycogen catabolic process(GO:0045819) |
| 0.4 | 1.3 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.4 | 2.2 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.4 | 3.6 | GO:0032218 | riboflavin transport(GO:0032218) |
| 0.4 | 1.3 | GO:1900111 | positive regulation of histone H3-K9 dimethylation(GO:1900111) |
| 0.4 | 1.3 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.4 | 1.3 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
| 0.4 | 1.7 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 0.4 | 1.3 | GO:0035498 | carnosine metabolic process(GO:0035498) |
| 0.4 | 5.6 | GO:0071493 | cellular response to UV-B(GO:0071493) |
| 0.4 | 3.0 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
| 0.4 | 3.0 | GO:0035934 | corticosterone secretion(GO:0035934) |
| 0.4 | 1.3 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
| 0.4 | 1.3 | GO:0006742 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.4 | 2.1 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.4 | 1.7 | GO:0003350 | pulmonary myocardium development(GO:0003350) |
| 0.4 | 5.1 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.4 | 2.1 | GO:0015692 | lead ion transport(GO:0015692) |
| 0.4 | 3.8 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
| 0.4 | 1.3 | GO:0048880 | sensory system development(GO:0048880) |
| 0.4 | 2.5 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 0.4 | 1.2 | GO:0043686 | co-translational protein modification(GO:0043686) |
| 0.4 | 4.5 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
| 0.4 | 1.2 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
| 0.4 | 2.0 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
| 0.4 | 2.0 | GO:0046208 | spermine catabolic process(GO:0046208) |
| 0.4 | 0.4 | GO:0034721 | histone H3-K4 demethylation, trimethyl-H3-K4-specific(GO:0034721) |
| 0.4 | 0.8 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
| 0.4 | 0.4 | GO:0071338 | submandibular salivary gland formation(GO:0060661) hair follicle cell proliferation(GO:0071335) regulation of hair follicle cell proliferation(GO:0071336) positive regulation of hair follicle cell proliferation(GO:0071338) |
| 0.4 | 3.6 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.4 | 1.6 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
| 0.4 | 0.4 | GO:0042756 | drinking behavior(GO:0042756) |
| 0.4 | 1.2 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
| 0.4 | 1.6 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
| 0.4 | 1.6 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
| 0.4 | 3.2 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
| 0.4 | 0.4 | GO:0042323 | negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
| 0.4 | 2.4 | GO:0035105 | sterol regulatory element binding protein import into nucleus(GO:0035105) |
| 0.4 | 0.8 | GO:1990834 | response to odorant(GO:1990834) |
| 0.4 | 0.4 | GO:0036466 | synaptic vesicle recycling via endosome(GO:0036466) |
| 0.4 | 1.2 | GO:1904328 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
| 0.4 | 1.2 | GO:0070898 | RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
| 0.4 | 1.2 | GO:0035425 | autocrine signaling(GO:0035425) |
| 0.4 | 1.2 | GO:0009644 | response to high light intensity(GO:0009644) |
| 0.4 | 1.2 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.4 | 0.4 | GO:1904732 | regulation of electron carrier activity(GO:1904732) |
| 0.4 | 1.2 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 0.4 | 3.5 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
| 0.4 | 0.4 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 0.4 | 0.4 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 0.4 | 1.2 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
| 0.4 | 1.9 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
| 0.4 | 12.0 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.4 | 3.1 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
| 0.4 | 37.1 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
| 0.4 | 1.5 | GO:0051177 | meiotic sister chromatid cohesion(GO:0051177) |
| 0.4 | 1.9 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
| 0.4 | 1.5 | GO:1900060 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.4 | 0.8 | GO:2000437 | regulation of monocyte extravasation(GO:2000437) |
| 0.4 | 2.3 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.4 | 2.6 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
| 0.4 | 3.0 | GO:0097052 | L-kynurenine metabolic process(GO:0097052) |
| 0.4 | 0.4 | GO:0098917 | retrograde trans-synaptic signaling(GO:0098917) |
| 0.4 | 1.1 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
| 0.4 | 3.7 | GO:0021633 | optic nerve structural organization(GO:0021633) |
| 0.4 | 0.4 | GO:0002590 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
| 0.4 | 1.5 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
| 0.4 | 0.7 | GO:1904204 | regulation of skeletal muscle hypertrophy(GO:1904204) |
| 0.4 | 2.6 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) |
| 0.4 | 1.8 | GO:0045779 | negative regulation of bone resorption(GO:0045779) |
| 0.4 | 2.9 | GO:0072719 | cellular response to cisplatin(GO:0072719) |
| 0.4 | 2.9 | GO:0033504 | floor plate development(GO:0033504) |
| 0.4 | 11.3 | GO:0048240 | sperm capacitation(GO:0048240) |
| 0.4 | 5.8 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 0.4 | 1.1 | GO:0071393 | cellular response to progesterone stimulus(GO:0071393) |
| 0.4 | 3.3 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
| 0.4 | 0.4 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) response to cyclosporin A(GO:1905237) |
| 0.4 | 1.1 | GO:0051714 | positive regulation of cytolysis in other organism(GO:0051714) |
| 0.4 | 1.4 | GO:0006477 | protein sulfation(GO:0006477) |
| 0.4 | 1.1 | GO:0030974 | thiamine pyrophosphate transport(GO:0030974) |
| 0.4 | 1.1 | GO:0071344 | diphosphate metabolic process(GO:0071344) |
| 0.4 | 2.1 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
| 0.4 | 0.4 | GO:1903217 | regulation of protein processing involved in protein targeting to mitochondrion(GO:1903216) negative regulation of protein processing involved in protein targeting to mitochondrion(GO:1903217) |
| 0.4 | 0.4 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
| 0.3 | 2.8 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.3 | 1.0 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
| 0.3 | 1.0 | GO:0060721 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
| 0.3 | 1.0 | GO:0019046 | release from viral latency(GO:0019046) |
| 0.3 | 1.0 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 0.3 | 1.4 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.3 | 1.0 | GO:0060739 | mesenchymal-epithelial cell signaling involved in prostate gland development(GO:0060739) |
| 0.3 | 0.7 | GO:0070836 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) caveola assembly(GO:0070836) |
| 0.3 | 4.1 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
| 0.3 | 0.7 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
| 0.3 | 2.1 | GO:0015811 | L-cystine transport(GO:0015811) |
| 0.3 | 3.1 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
| 0.3 | 1.4 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
| 0.3 | 2.7 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
| 0.3 | 1.7 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
| 0.3 | 1.7 | GO:0071918 | urea transmembrane transport(GO:0071918) |
| 0.3 | 0.7 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
| 0.3 | 1.7 | GO:0097577 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 0.3 | 7.5 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.3 | 0.7 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
| 0.3 | 1.7 | GO:0009446 | putrescine biosynthetic process(GO:0009446) putrescine biosynthetic process from ornithine(GO:0033387) |
| 0.3 | 1.0 | GO:0008355 | olfactory learning(GO:0008355) |
| 0.3 | 0.7 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
| 0.3 | 1.0 | GO:0018395 | peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine(GO:0018395) histone arginine demethylation(GO:0070077) histone H3-R2 demethylation(GO:0070078) histone H4-R3 demethylation(GO:0070079) |
| 0.3 | 1.0 | GO:0010513 | positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
| 0.3 | 1.0 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
| 0.3 | 1.3 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.3 | 0.7 | GO:0050755 | chemokine metabolic process(GO:0050755) |
| 0.3 | 4.0 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
| 0.3 | 0.3 | GO:0044026 | DNA hypermethylation(GO:0044026) |
| 0.3 | 1.0 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
| 0.3 | 0.7 | GO:1904580 | regulation of intracellular mRNA localization(GO:1904580) positive regulation of intracellular mRNA localization(GO:1904582) |
| 0.3 | 1.0 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.3 | 1.0 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
| 0.3 | 2.3 | GO:1901374 | acetate ester transport(GO:1901374) |
| 0.3 | 1.6 | GO:0070778 | L-aspartate transport(GO:0070778) L-aspartate transmembrane transport(GO:0089712) |
| 0.3 | 1.3 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 0.3 | 1.0 | GO:0032960 | regulation of inositol trisphosphate biosynthetic process(GO:0032960) positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
| 0.3 | 1.3 | GO:0030035 | microspike assembly(GO:0030035) |
| 0.3 | 1.6 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
| 0.3 | 2.6 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.3 | 3.6 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
| 0.3 | 3.5 | GO:1903944 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
| 0.3 | 1.6 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
| 0.3 | 1.9 | GO:0051182 | coenzyme transport(GO:0051182) |
| 0.3 | 1.3 | GO:0006617 | SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition(GO:0006617) |
| 0.3 | 2.2 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
| 0.3 | 0.3 | GO:0032909 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
| 0.3 | 0.9 | GO:0000103 | sulfate assimilation(GO:0000103) |
| 0.3 | 1.2 | GO:1904588 | cellular response to glycoprotein(GO:1904588) cellular response to thyrotropin-releasing hormone(GO:1905229) |
| 0.3 | 0.9 | GO:1903537 | meiotic spindle elongation(GO:0051232) meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
| 0.3 | 3.4 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.3 | 5.6 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
| 0.3 | 2.2 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.3 | 1.2 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
| 0.3 | 0.9 | GO:0001554 | luteolysis(GO:0001554) |
| 0.3 | 1.5 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
| 0.3 | 8.6 | GO:0006206 | pyrimidine nucleobase metabolic process(GO:0006206) |
| 0.3 | 7.7 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
| 0.3 | 0.9 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
| 0.3 | 1.8 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
| 0.3 | 0.9 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.3 | 0.3 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
| 0.3 | 0.6 | GO:1903576 | response to L-arginine(GO:1903576) |
| 0.3 | 0.6 | GO:0002326 | B cell lineage commitment(GO:0002326) |
| 0.3 | 2.4 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) |
| 0.3 | 0.3 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.3 | 0.3 | GO:0060327 | cytoplasmic actin-based contraction involved in cell motility(GO:0060327) |
| 0.3 | 0.9 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 0.3 | 0.6 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
| 0.3 | 0.3 | GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
| 0.3 | 0.6 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
| 0.3 | 0.9 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
| 0.3 | 0.9 | GO:0060166 | olfactory pit development(GO:0060166) |
| 0.3 | 2.4 | GO:0002118 | aggressive behavior(GO:0002118) |
| 0.3 | 5.9 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 0.3 | 8.8 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.3 | 0.3 | GO:0035915 | pore formation in membrane of other organism(GO:0035915) |
| 0.3 | 0.3 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
| 0.3 | 0.6 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
| 0.3 | 0.9 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
| 0.3 | 0.9 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
| 0.3 | 1.7 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
| 0.3 | 6.3 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
| 0.3 | 4.3 | GO:0006972 | hyperosmotic response(GO:0006972) |
| 0.3 | 1.1 | GO:0070922 | small RNA loading onto RISC(GO:0070922) |
| 0.3 | 0.6 | GO:0032849 | regulation of cellular pH reduction(GO:0032847) positive regulation of cellular pH reduction(GO:0032849) |
| 0.3 | 2.0 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.3 | 0.9 | GO:2000616 | negative regulation of histone H3-K9 acetylation(GO:2000616) |
| 0.3 | 2.0 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
| 0.3 | 1.4 | GO:2001074 | regulation of metanephric ureteric bud development(GO:2001074) positive regulation of metanephric ureteric bud development(GO:2001076) |
| 0.3 | 1.1 | GO:0031427 | response to methotrexate(GO:0031427) |
| 0.3 | 0.6 | GO:0001692 | histamine metabolic process(GO:0001692) |
| 0.3 | 1.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.3 | 0.3 | GO:0051673 | membrane disruption in other organism(GO:0051673) |
| 0.3 | 0.6 | GO:0033122 | negative regulation of purine nucleotide catabolic process(GO:0033122) |
| 0.3 | 0.3 | GO:0036035 | osteoclast development(GO:0036035) |
| 0.3 | 2.0 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
| 0.3 | 0.6 | GO:1904796 | regulation of core promoter binding(GO:1904796) |
| 0.3 | 0.3 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) |
| 0.3 | 2.0 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
| 0.3 | 2.0 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
| 0.3 | 1.1 | GO:1901318 | negative regulation of sperm motility(GO:1901318) |
| 0.3 | 1.1 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
| 0.3 | 2.2 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
| 0.3 | 2.0 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.3 | 0.3 | GO:0000255 | allantoin metabolic process(GO:0000255) |
| 0.3 | 0.8 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
| 0.3 | 0.6 | GO:0007356 | thorax and anterior abdomen determination(GO:0007356) |
| 0.3 | 1.4 | GO:0042713 | sperm ejaculation(GO:0042713) |
| 0.3 | 1.1 | GO:0032595 | B cell receptor transport within lipid bilayer(GO:0032595) B cell receptor transport into membrane raft(GO:0032597) protein transport out of membrane raft(GO:0032599) chemokine receptor transport out of membrane raft(GO:0032600) negative regulation of transforming growth factor beta3 production(GO:0032913) chemokine receptor transport within lipid bilayer(GO:0033606) |
| 0.3 | 16.6 | GO:0015701 | bicarbonate transport(GO:0015701) |
| 0.3 | 0.5 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
| 0.3 | 1.4 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
| 0.3 | 1.1 | GO:2000983 | regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
| 0.3 | 1.3 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
| 0.3 | 1.6 | GO:0098779 | mitophagy in response to mitochondrial depolarization(GO:0098779) |
| 0.3 | 0.5 | GO:1902732 | positive regulation of chondrocyte proliferation(GO:1902732) |
| 0.3 | 3.0 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
| 0.3 | 0.8 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
| 0.3 | 3.5 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
| 0.3 | 2.7 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
| 0.3 | 1.6 | GO:0016078 | tRNA catabolic process(GO:0016078) |
| 0.3 | 1.1 | GO:0098957 | anterograde axonal transport of mitochondrion(GO:0098957) |
| 0.3 | 0.5 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
| 0.3 | 2.4 | GO:1902219 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
| 0.3 | 5.6 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
| 0.3 | 13.2 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.3 | 1.6 | GO:0010957 | negative regulation of vitamin D biosynthetic process(GO:0010957) |
| 0.3 | 1.8 | GO:0001712 | ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
| 0.3 | 2.4 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
| 0.3 | 2.4 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
| 0.3 | 1.0 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
| 0.3 | 0.5 | GO:0021558 | trochlear nerve development(GO:0021558) |
| 0.3 | 1.0 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
| 0.3 | 0.3 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
| 0.3 | 2.1 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
| 0.3 | 2.6 | GO:0042256 | mature ribosome assembly(GO:0042256) |
| 0.3 | 0.8 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
| 0.3 | 1.5 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
| 0.3 | 0.3 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
| 0.3 | 2.8 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.3 | 0.8 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.3 | 1.5 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 0.3 | 1.5 | GO:0002760 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
| 0.3 | 1.8 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.3 | 1.3 | GO:2000035 | regulation of stem cell division(GO:2000035) |
| 0.3 | 0.8 | GO:0060298 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) positive regulation of sarcomere organization(GO:0060298) |
| 0.3 | 1.0 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
| 0.3 | 0.8 | GO:0003383 | apical constriction(GO:0003383) |
| 0.3 | 1.3 | GO:0048318 | axial mesoderm development(GO:0048318) |
| 0.3 | 1.0 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
| 0.3 | 3.3 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
| 0.3 | 1.5 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
| 0.2 | 1.0 | GO:0010587 | miRNA catabolic process(GO:0010587) |
| 0.2 | 1.7 | GO:0071420 | cellular response to histamine(GO:0071420) |
| 0.2 | 2.0 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
| 0.2 | 1.5 | GO:0000012 | single strand break repair(GO:0000012) |
| 0.2 | 1.7 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.2 | 10.6 | GO:0050832 | defense response to fungus(GO:0050832) |
| 0.2 | 3.7 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
| 0.2 | 2.7 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
| 0.2 | 2.0 | GO:0019236 | response to pheromone(GO:0019236) |
| 0.2 | 0.2 | GO:0032425 | positive regulation of mismatch repair(GO:0032425) |
| 0.2 | 0.5 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
| 0.2 | 0.2 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
| 0.2 | 0.2 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
| 0.2 | 0.5 | GO:0035624 | receptor transactivation(GO:0035624) |
| 0.2 | 1.2 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 0.2 | 1.0 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.2 | 6.3 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
| 0.2 | 0.2 | GO:0071231 | cellular response to folic acid(GO:0071231) |
| 0.2 | 4.4 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
| 0.2 | 1.2 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
| 0.2 | 4.6 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
| 0.2 | 0.5 | GO:0060482 | lobar bronchus epithelium development(GO:0060481) lobar bronchus development(GO:0060482) |
| 0.2 | 0.2 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
| 0.2 | 1.9 | GO:2001204 | regulation of osteoclast development(GO:2001204) |
| 0.2 | 0.5 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.2 | 1.2 | GO:0098780 | response to mitochondrial depolarisation(GO:0098780) |
| 0.2 | 0.5 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
| 0.2 | 1.4 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
| 0.2 | 2.4 | GO:0070572 | positive regulation of neuron projection regeneration(GO:0070572) |
| 0.2 | 0.5 | GO:2000182 | regulation of progesterone biosynthetic process(GO:2000182) |
| 0.2 | 0.2 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
| 0.2 | 0.2 | GO:0051105 | regulation of DNA ligation(GO:0051105) |
| 0.2 | 0.2 | GO:0030223 | neutrophil differentiation(GO:0030223) |
| 0.2 | 1.2 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
| 0.2 | 2.1 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
| 0.2 | 1.2 | GO:0090131 | mesenchyme migration(GO:0090131) |
| 0.2 | 1.4 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.2 | 0.7 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
| 0.2 | 0.2 | GO:2000812 | regulation of barbed-end actin filament capping(GO:2000812) |
| 0.2 | 1.4 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) amino sugar biosynthetic process(GO:0046349) |
| 0.2 | 1.2 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
| 0.2 | 0.5 | GO:1904170 | regulation of bleb assembly(GO:1904170) positive regulation of bleb assembly(GO:1904172) |
| 0.2 | 1.2 | GO:0006642 | triglyceride mobilization(GO:0006642) |
| 0.2 | 0.7 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
| 0.2 | 0.7 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
| 0.2 | 6.9 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
| 0.2 | 1.4 | GO:0010666 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.2 | 1.6 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
| 0.2 | 0.9 | GO:0097476 | spinal cord motor neuron migration(GO:0097476) |
| 0.2 | 0.7 | GO:0018201 | N-terminal protein amino acid methylation(GO:0006480) N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) peptidyl-glycine modification(GO:0018201) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
| 0.2 | 1.4 | GO:0034227 | tRNA thio-modification(GO:0034227) |
| 0.2 | 0.5 | GO:0045357 | interferon-beta biosynthetic process(GO:0045350) regulation of interferon-beta biosynthetic process(GO:0045357) positive regulation of interferon-beta biosynthetic process(GO:0045359) |
| 0.2 | 5.9 | GO:1900116 | extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
| 0.2 | 2.3 | GO:0032930 | positive regulation of superoxide anion generation(GO:0032930) |
| 0.2 | 0.5 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
| 0.2 | 3.8 | GO:0072619 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.2 | 0.5 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) positive regulation of calcium:sodium antiporter activity(GO:1903281) |
| 0.2 | 0.2 | GO:0015670 | carbon dioxide transport(GO:0015670) |
| 0.2 | 1.1 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
| 0.2 | 1.3 | GO:0060988 | lipid tube assembly(GO:0060988) |
| 0.2 | 2.0 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
| 0.2 | 0.4 | GO:1903059 | regulation of protein lipidation(GO:1903059) |
| 0.2 | 0.4 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
| 0.2 | 0.2 | GO:0036245 | cellular response to menadione(GO:0036245) |
| 0.2 | 1.3 | GO:0071104 | response to interleukin-9(GO:0071104) |
| 0.2 | 1.1 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
| 0.2 | 0.2 | GO:0030432 | peristalsis(GO:0030432) |
| 0.2 | 2.9 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
| 0.2 | 1.8 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.2 | 1.3 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
| 0.2 | 1.3 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.2 | 1.3 | GO:0019060 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.2 | 7.5 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
| 0.2 | 1.5 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
| 0.2 | 0.7 | GO:0001866 | NK T cell proliferation(GO:0001866) |
| 0.2 | 1.8 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.2 | 3.7 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
| 0.2 | 4.1 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.2 | 0.7 | GO:2000542 | negative regulation of endodermal cell differentiation(GO:1903225) negative regulation of gastrulation(GO:2000542) |
| 0.2 | 18.0 | GO:0050672 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) |
| 0.2 | 1.9 | GO:0035986 | senescence-associated heterochromatin focus assembly(GO:0035986) |
| 0.2 | 1.1 | GO:0007056 | spindle assembly involved in female meiosis(GO:0007056) |
| 0.2 | 3.9 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
| 0.2 | 0.2 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
| 0.2 | 1.9 | GO:0010818 | T cell chemotaxis(GO:0010818) |
| 0.2 | 0.2 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
| 0.2 | 0.4 | GO:1990418 | response to insulin-like growth factor stimulus(GO:1990418) |
| 0.2 | 1.3 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.2 | 0.6 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
| 0.2 | 0.2 | GO:0009726 | detection of endogenous stimulus(GO:0009726) |
| 0.2 | 0.2 | GO:1903935 | response to sodium arsenite(GO:1903935) |
| 0.2 | 0.2 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
| 0.2 | 0.6 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
| 0.2 | 2.3 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
| 0.2 | 20.2 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.2 | 3.2 | GO:0016576 | histone dephosphorylation(GO:0016576) |
| 0.2 | 0.2 | GO:1904397 | negative regulation of neuromuscular junction development(GO:1904397) |
| 0.2 | 0.4 | GO:0045759 | negative regulation of action potential(GO:0045759) |
| 0.2 | 3.1 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
| 0.2 | 2.3 | GO:0040016 | embryonic cleavage(GO:0040016) |
| 0.2 | 2.7 | GO:0071435 | potassium ion export(GO:0071435) |
| 0.2 | 0.6 | GO:0000451 | rRNA 2'-O-methylation(GO:0000451) |
| 0.2 | 3.3 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
| 0.2 | 1.9 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.2 | 2.3 | GO:0048311 | mitochondrion distribution(GO:0048311) |
| 0.2 | 0.6 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
| 0.2 | 0.2 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
| 0.2 | 0.2 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
| 0.2 | 1.4 | GO:0016559 | peroxisome fission(GO:0016559) |
| 0.2 | 0.8 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
| 0.2 | 1.2 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
| 0.2 | 0.6 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.2 | 0.6 | GO:0039692 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) |
| 0.2 | 4.1 | GO:0046885 | regulation of hormone biosynthetic process(GO:0046885) |
| 0.2 | 2.0 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.2 | 2.0 | GO:0002475 | antigen processing and presentation via MHC class Ib(GO:0002475) antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 0.2 | 0.6 | GO:0009386 | translational attenuation(GO:0009386) |
| 0.2 | 0.6 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
| 0.2 | 0.4 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
| 0.2 | 0.6 | GO:0001207 | histone displacement(GO:0001207) positive regulation of transcription involved in meiotic cell cycle(GO:0051039) |
| 0.2 | 0.6 | GO:0010626 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) |
| 0.2 | 2.2 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.2 | 0.2 | GO:0006106 | fumarate metabolic process(GO:0006106) |
| 0.2 | 0.8 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
| 0.2 | 0.4 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
| 0.2 | 1.0 | GO:0090166 | Golgi disassembly(GO:0090166) |
| 0.2 | 1.8 | GO:0032808 | lacrimal gland development(GO:0032808) |
| 0.2 | 0.4 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.2 | 0.4 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) regulation of kinetochore assembly(GO:0090234) |
| 0.2 | 1.5 | GO:0002254 | kinin cascade(GO:0002254) plasma kallikrein-kinin cascade(GO:0002353) |
| 0.2 | 2.5 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
| 0.2 | 1.3 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
| 0.2 | 0.4 | GO:1901877 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
| 0.2 | 0.4 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
| 0.2 | 1.7 | GO:0070475 | rRNA base methylation(GO:0070475) |
| 0.2 | 0.6 | GO:0001189 | RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
| 0.2 | 0.9 | GO:0048254 | snoRNA localization(GO:0048254) |
| 0.2 | 0.6 | GO:0071962 | mitotic sister chromatid cohesion, centromeric(GO:0071962) |
| 0.2 | 1.1 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
| 0.2 | 2.5 | GO:0060180 | female mating behavior(GO:0060180) |
| 0.2 | 0.4 | GO:1902080 | regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
| 0.2 | 3.2 | GO:0046069 | cGMP catabolic process(GO:0046069) |
| 0.2 | 0.8 | GO:1901550 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
| 0.2 | 6.2 | GO:0030488 | tRNA methylation(GO:0030488) |
| 0.2 | 0.2 | GO:1902563 | regulation of neutrophil activation(GO:1902563) |
| 0.2 | 4.1 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
| 0.2 | 2.0 | GO:0032060 | bleb assembly(GO:0032060) |
| 0.2 | 0.6 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
| 0.2 | 0.6 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
| 0.2 | 0.2 | GO:0019086 | late viral transcription(GO:0019086) |
| 0.2 | 1.3 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.2 | 0.6 | GO:1903570 | regulation of protein kinase D signaling(GO:1903570) positive regulation of protein kinase D signaling(GO:1903572) |
| 0.2 | 0.6 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
| 0.2 | 0.9 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
| 0.2 | 0.4 | GO:0021834 | chemorepulsion involved in embryonic olfactory bulb interneuron precursor migration(GO:0021834) |
| 0.2 | 0.2 | GO:0072107 | regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
| 0.2 | 0.4 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
| 0.2 | 0.5 | GO:0008272 | sulfate transport(GO:0008272) |
| 0.2 | 0.4 | GO:0072423 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
| 0.2 | 6.0 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
| 0.2 | 0.2 | GO:0032532 | regulation of microvillus length(GO:0032532) |
| 0.2 | 0.4 | GO:0060369 | positive regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060369) |
| 0.2 | 5.1 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.2 | 0.5 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
| 0.2 | 3.8 | GO:1901070 | guanosine-containing compound biosynthetic process(GO:1901070) |
| 0.2 | 1.1 | GO:0002176 | male germ cell proliferation(GO:0002176) germ cell proliferation(GO:0036093) |
| 0.2 | 0.4 | GO:0072103 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
| 0.2 | 1.3 | GO:0071554 | cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
| 0.2 | 0.4 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
| 0.2 | 1.3 | GO:0071481 | cellular response to X-ray(GO:0071481) |
| 0.2 | 2.5 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
| 0.2 | 0.5 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
| 0.2 | 1.1 | GO:0019264 | glycine biosynthetic process from serine(GO:0019264) |
| 0.2 | 1.1 | GO:0051280 | negative regulation of release of sequestered calcium ion into cytosol(GO:0051280) positive regulation of sequestering of calcium ion(GO:0051284) |
| 0.2 | 0.7 | GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
| 0.2 | 0.2 | GO:0010958 | regulation of amino acid import(GO:0010958) |
| 0.2 | 1.1 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.2 | 2.3 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
| 0.2 | 1.4 | GO:0016926 | protein desumoylation(GO:0016926) |
| 0.2 | 1.6 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
| 0.2 | 0.9 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
| 0.2 | 0.3 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
| 0.2 | 0.5 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
| 0.2 | 3.6 | GO:0051764 | actin crosslink formation(GO:0051764) |
| 0.2 | 0.3 | GO:0046110 | xanthine metabolic process(GO:0046110) |
| 0.2 | 1.7 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
| 0.2 | 0.5 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 0.2 | 0.9 | GO:2000543 | positive regulation of gastrulation(GO:2000543) |
| 0.2 | 0.3 | GO:0048867 | stem cell fate determination(GO:0048867) |
| 0.2 | 0.2 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
| 0.2 | 0.3 | GO:0061056 | sclerotome development(GO:0061056) |
| 0.2 | 0.9 | GO:0071494 | cellular response to UV-C(GO:0071494) |
| 0.2 | 0.3 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
| 0.2 | 2.2 | GO:1901071 | glucosamine-containing compound metabolic process(GO:1901071) |
| 0.2 | 0.7 | GO:0034184 | regulation of maintenance of sister chromatid cohesion(GO:0034091) positive regulation of maintenance of sister chromatid cohesion(GO:0034093) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
| 0.2 | 0.2 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
| 0.2 | 0.3 | GO:0021548 | pons development(GO:0021548) |
| 0.2 | 0.7 | GO:0086021 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
| 0.2 | 3.4 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
| 0.2 | 0.2 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
| 0.2 | 0.7 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.2 | 0.3 | GO:1903233 | regulation of calcium ion-dependent exocytosis of neurotransmitter(GO:1903233) |
| 0.2 | 2.4 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
| 0.2 | 2.4 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
| 0.2 | 0.2 | GO:0003175 | tricuspid valve development(GO:0003175) tricuspid valve morphogenesis(GO:0003186) |
| 0.2 | 0.7 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
| 0.2 | 4.7 | GO:0098926 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
| 0.2 | 0.5 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
| 0.2 | 1.5 | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
| 0.2 | 1.2 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.2 | 0.7 | GO:0043335 | protein unfolding(GO:0043335) |
| 0.2 | 0.7 | GO:1904021 | negative regulation of G-protein coupled receptor internalization(GO:1904021) |
| 0.2 | 0.2 | GO:0043006 | activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
| 0.2 | 2.8 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
| 0.2 | 0.6 | GO:0003404 | optic vesicle morphogenesis(GO:0003404) optic cup structural organization(GO:0003409) |
| 0.2 | 2.3 | GO:0001553 | luteinization(GO:0001553) |
| 0.2 | 0.5 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
| 0.2 | 0.3 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
| 0.2 | 0.2 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.2 | 0.3 | GO:0048105 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
| 0.2 | 0.3 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
| 0.2 | 0.2 | GO:0036022 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
| 0.2 | 1.1 | GO:1903817 | negative regulation of voltage-gated potassium channel activity(GO:1903817) |
| 0.2 | 0.6 | GO:0090096 | regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 0.2 | 0.2 | GO:0072298 | regulation of metanephric glomerulus development(GO:0072298) |
| 0.2 | 0.6 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 0.2 | 0.6 | GO:0016334 | morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
| 0.2 | 0.3 | GO:0044752 | response to human chorionic gonadotropin(GO:0044752) |
| 0.2 | 0.5 | GO:0003164 | His-Purkinje system development(GO:0003164) |
| 0.2 | 0.9 | GO:0008218 | bioluminescence(GO:0008218) |
| 0.2 | 1.7 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
| 0.2 | 1.6 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.2 | 0.6 | GO:0090063 | positive regulation of microtubule nucleation(GO:0090063) |
| 0.2 | 1.1 | GO:1902856 | negative regulation of nonmotile primary cilium assembly(GO:1902856) |
| 0.2 | 0.5 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
| 0.2 | 7.8 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
| 0.2 | 0.5 | GO:0035574 | histone H4-K20 demethylation(GO:0035574) |
| 0.2 | 0.5 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
| 0.2 | 0.5 | GO:0072086 | specification of loop of Henle identity(GO:0072086) |
| 0.2 | 0.9 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
| 0.2 | 0.2 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.2 | 0.8 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
| 0.2 | 0.3 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 0.2 | 0.9 | GO:0046469 | platelet activating factor metabolic process(GO:0046469) |
| 0.2 | 0.5 | GO:1904862 | inhibitory synapse assembly(GO:1904862) |
| 0.2 | 1.4 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.2 | 0.6 | GO:0070378 | positive regulation of ERK5 cascade(GO:0070378) |
| 0.2 | 1.5 | GO:0060033 | anatomical structure regression(GO:0060033) |
| 0.2 | 0.6 | GO:1903575 | cornified envelope assembly(GO:1903575) |
| 0.1 | 2.8 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
| 0.1 | 1.5 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.1 | 0.6 | GO:2000314 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 0.1 | 4.1 | GO:0019835 | cytolysis(GO:0019835) |
| 0.1 | 1.7 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
| 0.1 | 0.3 | GO:1904529 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 0.1 | 1.3 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
| 0.1 | 0.3 | GO:0036269 | swimming behavior(GO:0036269) |
| 0.1 | 0.6 | GO:0035455 | response to interferon-alpha(GO:0035455) |
| 0.1 | 0.4 | GO:0072334 | UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
| 0.1 | 0.3 | GO:0098937 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
| 0.1 | 0.7 | GO:1903232 | melanosome assembly(GO:1903232) |
| 0.1 | 0.4 | GO:0019755 | one-carbon compound transport(GO:0019755) |
| 0.1 | 0.3 | GO:0009227 | nucleotide-sugar catabolic process(GO:0009227) |
| 0.1 | 5.7 | GO:1903146 | regulation of mitophagy(GO:1903146) |
| 0.1 | 1.1 | GO:0043578 | nuclear matrix organization(GO:0043578) |
| 0.1 | 1.0 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
| 0.1 | 0.4 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
| 0.1 | 0.4 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 0.1 | 0.8 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
| 0.1 | 1.0 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
| 0.1 | 0.3 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
| 0.1 | 0.1 | GO:0038170 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.1 | 4.1 | GO:0050427 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.1 | 0.6 | GO:0019348 | dolichol metabolic process(GO:0019348) |
| 0.1 | 0.7 | GO:0015820 | leucine transport(GO:0015820) |
| 0.1 | 0.7 | GO:0060017 | parathyroid gland development(GO:0060017) |
| 0.1 | 0.8 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
| 0.1 | 0.7 | GO:0035799 | ureter maturation(GO:0035799) |
| 0.1 | 0.7 | GO:1903273 | protein glutathionylation(GO:0010731) regulation of protein glutathionylation(GO:0010732) negative regulation of protein glutathionylation(GO:0010734) regulation of sodium ion export(GO:1903273) positive regulation of sodium ion export(GO:1903275) regulation of sodium ion export from cell(GO:1903276) positive regulation of sodium ion export from cell(GO:1903278) |
| 0.1 | 0.3 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
| 0.1 | 0.7 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
| 0.1 | 0.8 | GO:0060056 | mammary gland involution(GO:0060056) |
| 0.1 | 11.1 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
| 0.1 | 0.3 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
| 0.1 | 1.9 | GO:1904869 | regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) |
| 0.1 | 7.1 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
| 0.1 | 1.1 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
| 0.1 | 2.8 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.1 | 1.9 | GO:0015816 | glycine transport(GO:0015816) |
| 0.1 | 0.1 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
| 0.1 | 0.4 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.1 | 1.2 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
| 0.1 | 1.1 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.1 | 0.8 | GO:0035995 | detection of muscle stretch(GO:0035995) |
| 0.1 | 0.4 | GO:0005999 | xylulose biosynthetic process(GO:0005999) |
| 0.1 | 0.9 | GO:0046618 | drug export(GO:0046618) |
| 0.1 | 0.7 | GO:1990928 | response to amino acid starvation(GO:1990928) |
| 0.1 | 0.3 | GO:1902741 | interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
| 0.1 | 1.3 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 0.1 | 2.1 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.1 | 0.3 | GO:0061743 | motor learning(GO:0061743) |
| 0.1 | 0.4 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 0.1 | 0.9 | GO:0044110 | growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) |
| 0.1 | 0.5 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.1 | 1.3 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.1 | 1.8 | GO:1903543 | positive regulation of exosomal secretion(GO:1903543) |
| 0.1 | 0.4 | GO:0000706 | meiotic DNA double-strand break processing(GO:0000706) |
| 0.1 | 0.6 | GO:1900223 | positive regulation of beta-amyloid clearance(GO:1900223) |
| 0.1 | 0.6 | GO:0043129 | surfactant homeostasis(GO:0043129) |
| 0.1 | 0.4 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
| 0.1 | 2.7 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.1 | 0.8 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
| 0.1 | 5.1 | GO:0090383 | phagosome acidification(GO:0090383) |
| 0.1 | 0.4 | GO:0018874 | benzoate metabolic process(GO:0018874) |
| 0.1 | 1.1 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 0.1 | 0.1 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
| 0.1 | 0.4 | GO:0043400 | glucocorticoid secretion(GO:0035933) cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) negative regulation of cortisol secretion(GO:0051463) negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) regulation of glucocorticoid secretion(GO:2000849) negative regulation of glucocorticoid secretion(GO:2000850) |
| 0.1 | 1.0 | GO:1902661 | positive regulation of glucose mediated signaling pathway(GO:1902661) |
| 0.1 | 0.8 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
| 0.1 | 0.9 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
| 0.1 | 0.4 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
| 0.1 | 0.1 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
| 0.1 | 0.1 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.1 | 1.5 | GO:0097116 | gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
| 0.1 | 1.6 | GO:0021670 | lateral ventricle development(GO:0021670) |
| 0.1 | 4.6 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
| 0.1 | 0.6 | GO:0048664 | neuron fate determination(GO:0048664) |
| 0.1 | 0.6 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
| 0.1 | 0.1 | GO:1900155 | regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
| 0.1 | 1.1 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
| 0.1 | 0.1 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
| 0.1 | 0.1 | GO:2000275 | cellular amide catabolic process(GO:0043605) regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
| 0.1 | 0.6 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
| 0.1 | 0.2 | GO:0035930 | corticosteroid hormone secretion(GO:0035930) |
| 0.1 | 6.5 | GO:0043486 | histone exchange(GO:0043486) |
| 0.1 | 2.0 | GO:0071402 | cellular response to lipoprotein particle stimulus(GO:0071402) |
| 0.1 | 0.2 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.1 | 3.5 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
| 0.1 | 1.2 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
| 0.1 | 0.2 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
| 0.1 | 0.4 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
| 0.1 | 0.7 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
| 0.1 | 0.5 | GO:0034241 | macrophage fusion(GO:0034238) regulation of macrophage fusion(GO:0034239) positive regulation of macrophage fusion(GO:0034241) |
| 0.1 | 0.6 | GO:0034334 | adherens junction maintenance(GO:0034334) |
| 0.1 | 0.4 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
| 0.1 | 0.5 | GO:0006108 | malate metabolic process(GO:0006108) |
| 0.1 | 0.5 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.1 | 1.0 | GO:0061709 | reticulophagy(GO:0061709) |
| 0.1 | 0.4 | GO:0090646 | mitochondrial tRNA processing(GO:0090646) mitochondrial tRNA 3'-end processing(GO:1990180) |
| 0.1 | 1.5 | GO:0051639 | actin filament network formation(GO:0051639) |
| 0.1 | 1.1 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
| 0.1 | 0.6 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
| 0.1 | 0.6 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
| 0.1 | 0.6 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.1 | 1.4 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 0.1 | 0.3 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
| 0.1 | 1.2 | GO:1903071 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
| 0.1 | 0.9 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
| 0.1 | 2.5 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 0.1 | 0.3 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.1 | 0.1 | GO:0060368 | regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
| 0.1 | 0.7 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
| 0.1 | 1.7 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
| 0.1 | 1.0 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.1 | 1.1 | GO:0035872 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) |
| 0.1 | 0.3 | GO:0045425 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045425) |
| 0.1 | 0.1 | GO:0032230 | positive regulation of synaptic transmission, GABAergic(GO:0032230) |
| 0.1 | 0.2 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
| 0.1 | 0.3 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
| 0.1 | 1.7 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.1 | 8.0 | GO:0034340 | response to type I interferon(GO:0034340) |
| 0.1 | 1.2 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
| 0.1 | 0.6 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
| 0.1 | 0.9 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.1 | 0.3 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
| 0.1 | 0.2 | GO:0038178 | complement component C5a signaling pathway(GO:0038178) |
| 0.1 | 0.8 | GO:0008063 | Toll signaling pathway(GO:0008063) |
| 0.1 | 0.6 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.1 | 0.1 | GO:0002029 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
| 0.1 | 5.3 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
| 0.1 | 0.1 | GO:0070474 | positive regulation of uterine smooth muscle contraction(GO:0070474) |
| 0.1 | 1.1 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) |
| 0.1 | 0.3 | GO:1904897 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
| 0.1 | 4.7 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
| 0.1 | 0.1 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
| 0.1 | 1.7 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
| 0.1 | 3.7 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.1 | 0.2 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.1 | 0.2 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
| 0.1 | 0.4 | GO:0042560 | folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 0.1 | 0.5 | GO:0032439 | endosome localization(GO:0032439) |
| 0.1 | 1.1 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
| 0.1 | 0.5 | GO:0007000 | nucleolus organization(GO:0007000) |
| 0.1 | 0.3 | GO:1900138 | negative regulation of phospholipase A2 activity(GO:1900138) |
| 0.1 | 0.2 | GO:0042748 | circadian sleep/wake cycle, non-REM sleep(GO:0042748) |
| 0.1 | 0.4 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
| 0.1 | 1.4 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.1 | 3.0 | GO:0006400 | tRNA modification(GO:0006400) |
| 0.1 | 1.9 | GO:0044241 | lipid digestion(GO:0044241) |
| 0.1 | 0.7 | GO:0007512 | adult heart development(GO:0007512) |
| 0.1 | 0.6 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
| 0.1 | 0.2 | GO:0060022 | hard palate development(GO:0060022) |
| 0.1 | 0.3 | GO:0002922 | positive regulation of humoral immune response(GO:0002922) |
| 0.1 | 0.6 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
| 0.1 | 0.3 | GO:0006489 | dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
| 0.1 | 1.6 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
| 0.1 | 1.5 | GO:0097186 | amelogenesis(GO:0097186) |
| 0.1 | 0.4 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
| 0.1 | 0.7 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
| 0.1 | 0.2 | GO:1903726 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) negative regulation of phospholipid metabolic process(GO:1903726) |
| 0.1 | 0.3 | GO:0072233 | thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
| 0.1 | 0.5 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
| 0.1 | 0.4 | GO:0043587 | tongue morphogenesis(GO:0043587) |
| 0.1 | 2.0 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.1 | 0.9 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.1 | 0.3 | GO:1990519 | pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
| 0.1 | 0.5 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
| 0.1 | 1.2 | GO:0060013 | righting reflex(GO:0060013) |
| 0.1 | 0.2 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
| 0.1 | 0.4 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
| 0.1 | 0.3 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
| 0.1 | 2.0 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
| 0.1 | 0.3 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) positive regulation of microtubule binding(GO:1904528) |
| 0.1 | 0.9 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.1 | 3.3 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
| 0.1 | 0.4 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
| 0.1 | 2.9 | GO:0035036 | sperm-egg recognition(GO:0035036) |
| 0.1 | 0.8 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.1 | 0.8 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
| 0.1 | 0.9 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
| 0.1 | 0.2 | GO:0042779 | tRNA 3'-trailer cleavage, endonucleolytic(GO:0034414) tRNA 3'-trailer cleavage(GO:0042779) |
| 0.1 | 0.5 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
| 0.1 | 0.6 | GO:0006828 | manganese ion transport(GO:0006828) |
| 0.1 | 0.2 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
| 0.1 | 0.8 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.1 | 0.6 | GO:0000212 | meiotic spindle organization(GO:0000212) |
| 0.1 | 2.3 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
| 0.1 | 1.6 | GO:0017121 | phospholipid scrambling(GO:0017121) |
| 0.1 | 0.8 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.1 | 2.7 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
| 0.1 | 0.7 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
| 0.1 | 0.4 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
| 0.1 | 0.3 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
| 0.1 | 1.3 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.1 | 5.3 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
| 0.1 | 0.5 | GO:0002933 | lipid hydroxylation(GO:0002933) |
| 0.1 | 0.5 | GO:0097396 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.1 | 2.0 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
| 0.1 | 0.5 | GO:0071233 | cellular response to leucine(GO:0071233) |
| 0.1 | 1.2 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
| 0.1 | 0.3 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
| 0.1 | 0.2 | GO:0060346 | bone trabecula formation(GO:0060346) |
| 0.1 | 0.5 | GO:0044571 | [2Fe-2S] cluster assembly(GO:0044571) |
| 0.1 | 0.2 | GO:1904562 | phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
| 0.1 | 0.4 | GO:0000961 | negative regulation of mitochondrial RNA catabolic process(GO:0000961) |
| 0.1 | 0.4 | GO:2001034 | positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
| 0.1 | 0.3 | GO:0002769 | natural killer cell inhibitory signaling pathway(GO:0002769) |
| 0.1 | 6.0 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
| 0.1 | 0.4 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
| 0.1 | 1.9 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
| 0.1 | 2.7 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) |
| 0.1 | 0.3 | GO:0015942 | formate metabolic process(GO:0015942) |
| 0.1 | 2.5 | GO:0030199 | collagen fibril organization(GO:0030199) |
| 0.1 | 0.3 | GO:0003190 | atrioventricular valve formation(GO:0003190) |
| 0.1 | 0.9 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.1 | 0.9 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
| 0.1 | 0.3 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.1 | 0.6 | GO:0033572 | transferrin transport(GO:0033572) |
| 0.1 | 2.9 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
| 0.1 | 0.3 | GO:0061182 | negative regulation of chondrocyte development(GO:0061182) |
| 0.1 | 0.7 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
| 0.1 | 0.7 | GO:0043248 | proteasome assembly(GO:0043248) |
| 0.1 | 0.2 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
| 0.1 | 0.3 | GO:0042262 | DNA protection(GO:0042262) |
| 0.1 | 6.8 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
| 0.1 | 0.3 | GO:1902723 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 0.1 | 1.6 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
| 0.1 | 0.2 | GO:0002759 | regulation of antimicrobial humoral response(GO:0002759) |
| 0.1 | 0.4 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
| 0.1 | 0.5 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
| 0.1 | 0.3 | GO:2000490 | negative regulation of hepatic stellate cell activation(GO:2000490) |
| 0.1 | 0.2 | GO:0015855 | pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
| 0.1 | 1.1 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
| 0.1 | 0.2 | GO:0007343 | egg activation(GO:0007343) |
| 0.1 | 0.8 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 0.1 | 0.8 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.1 | 0.2 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
| 0.1 | 1.4 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.1 | 0.4 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
| 0.1 | 0.3 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
| 0.1 | 0.3 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
| 0.1 | 0.5 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
| 0.1 | 0.7 | GO:0060134 | prepulse inhibition(GO:0060134) |
| 0.1 | 0.1 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) |
| 0.1 | 0.2 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
| 0.1 | 0.7 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
| 0.1 | 0.2 | GO:0002092 | positive regulation of receptor internalization(GO:0002092) |
| 0.1 | 0.2 | GO:1903259 | exon-exon junction complex disassembly(GO:1903259) |
| 0.1 | 1.0 | GO:0072661 | protein targeting to plasma membrane(GO:0072661) |
| 0.1 | 1.2 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
| 0.1 | 0.2 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
| 0.1 | 0.2 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
| 0.1 | 0.2 | GO:0002384 | hepatic immune response(GO:0002384) |
| 0.1 | 0.4 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
| 0.1 | 0.6 | GO:0090197 | chemokine secretion(GO:0090195) regulation of chemokine secretion(GO:0090196) positive regulation of chemokine secretion(GO:0090197) |
| 0.1 | 3.2 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
| 0.1 | 0.2 | GO:0035638 | patched ligand maturation(GO:0007225) signal maturation(GO:0035638) |
| 0.1 | 0.1 | GO:1902617 | response to fluoride(GO:1902617) |
| 0.1 | 0.8 | GO:1901186 | positive regulation of ERBB signaling pathway(GO:1901186) |
| 0.1 | 0.1 | GO:0051935 | amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
| 0.1 | 0.4 | GO:0033058 | directional locomotion(GO:0033058) |
| 0.1 | 0.2 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
| 0.1 | 0.2 | GO:0033386 | geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
| 0.1 | 0.2 | GO:0018160 | peptidyl-pyrromethane cofactor linkage(GO:0018160) |
| 0.1 | 0.2 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
| 0.1 | 0.1 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
| 0.1 | 1.1 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.1 | 2.3 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
| 0.1 | 0.6 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
| 0.1 | 0.6 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
| 0.1 | 0.3 | GO:0072092 | ureteric bud invasion(GO:0072092) |
| 0.1 | 0.5 | GO:0000733 | DNA strand renaturation(GO:0000733) |
| 0.1 | 0.3 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
| 0.1 | 1.0 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.1 | 0.3 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
| 0.1 | 0.1 | GO:0031990 | mRNA export from nucleus in response to heat stress(GO:0031990) |
| 0.1 | 0.1 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
| 0.1 | 0.8 | GO:0097240 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
| 0.1 | 0.4 | GO:2000047 | regulation of cell-cell adhesion mediated by cadherin(GO:2000047) |
| 0.1 | 0.1 | GO:2000861 | estrogen secretion(GO:0035937) estradiol secretion(GO:0035938) regulation of estrogen secretion(GO:2000861) regulation of estradiol secretion(GO:2000864) |
| 0.1 | 0.3 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
| 0.1 | 5.9 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
| 0.1 | 0.2 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
| 0.1 | 0.3 | GO:0070444 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 0.1 | 0.1 | GO:0030573 | bile acid catabolic process(GO:0030573) |
| 0.1 | 0.2 | GO:0048560 | establishment of anatomical structure orientation(GO:0048560) |
| 0.1 | 0.3 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
| 0.1 | 1.1 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
| 0.1 | 0.1 | GO:0006561 | proline biosynthetic process(GO:0006561) |
| 0.1 | 0.3 | GO:0051758 | homologous chromosome movement towards spindle pole involved in homologous chromosome segregation(GO:0051758) |
| 0.1 | 0.3 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
| 0.1 | 0.2 | GO:1904808 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
| 0.1 | 0.4 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
| 0.1 | 0.1 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
| 0.1 | 0.1 | GO:1900365 | positive regulation of mRNA polyadenylation(GO:1900365) |
| 0.1 | 0.4 | GO:0006543 | glutamine catabolic process(GO:0006543) |
| 0.1 | 0.3 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
| 0.1 | 0.5 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.1 | 1.1 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
| 0.1 | 0.3 | GO:0018094 | protein polyglycylation(GO:0018094) |
| 0.1 | 0.2 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.1 | 0.6 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
| 0.1 | 0.4 | GO:0002335 | mature B cell differentiation(GO:0002335) |
| 0.1 | 0.4 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
| 0.1 | 0.2 | GO:0090119 | vesicle-mediated cholesterol transport(GO:0090119) |
| 0.1 | 1.7 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.1 | 0.2 | GO:0048058 | compound eye corneal lens development(GO:0048058) |
| 0.1 | 1.2 | GO:0097034 | mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.1 | 0.3 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
| 0.1 | 0.2 | GO:0071422 | succinate transport(GO:0015744) succinate transmembrane transport(GO:0071422) |
| 0.1 | 1.8 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
| 0.1 | 0.3 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
| 0.1 | 0.4 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
| 0.1 | 0.2 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 0.1 | 0.6 | GO:0001675 | acrosome assembly(GO:0001675) |
| 0.1 | 0.4 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
| 0.1 | 0.2 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
| 0.1 | 0.4 | GO:0035897 | proteolysis in other organism(GO:0035897) |
| 0.1 | 0.2 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
| 0.1 | 4.3 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
| 0.1 | 0.2 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) protein K33-linked deubiquitination(GO:1990168) |
| 0.1 | 0.5 | GO:0032196 | transposition(GO:0032196) |
| 0.1 | 0.4 | GO:0006068 | ethanol catabolic process(GO:0006068) |
| 0.1 | 0.2 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.1 | 0.5 | GO:0042749 | regulation of circadian sleep/wake cycle(GO:0042749) |
| 0.1 | 0.5 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
| 0.1 | 0.3 | GO:0050957 | equilibrioception(GO:0050957) |
| 0.1 | 0.6 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
| 0.1 | 0.8 | GO:0048665 | neuron fate specification(GO:0048665) |
| 0.1 | 0.7 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
| 0.1 | 0.3 | GO:0046103 | adenosine catabolic process(GO:0006154) inosine biosynthetic process(GO:0046103) |
| 0.1 | 0.1 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
| 0.1 | 0.5 | GO:2000680 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
| 0.1 | 1.2 | GO:0042572 | retinol metabolic process(GO:0042572) |
| 0.1 | 7.4 | GO:0038096 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
| 0.1 | 0.2 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
| 0.1 | 0.3 | GO:0019682 | glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
| 0.1 | 2.3 | GO:0007077 | mitotic nuclear envelope disassembly(GO:0007077) |
| 0.1 | 0.5 | GO:2001222 | regulation of neuron migration(GO:2001222) |
| 0.1 | 0.1 | GO:0043324 | eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
| 0.1 | 0.2 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
| 0.1 | 1.4 | GO:0021762 | substantia nigra development(GO:0021762) |
| 0.1 | 0.1 | GO:0016488 | sesquiterpenoid metabolic process(GO:0006714) sesquiterpenoid catabolic process(GO:0016107) farnesol metabolic process(GO:0016487) farnesol catabolic process(GO:0016488) |
| 0.1 | 0.2 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
| 0.1 | 0.3 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
| 0.1 | 0.4 | GO:0036499 | PERK-mediated unfolded protein response(GO:0036499) |
| 0.0 | 0.4 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
| 0.0 | 0.0 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
| 0.0 | 0.2 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
| 0.0 | 0.1 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
| 0.0 | 0.2 | GO:0007144 | female meiosis I(GO:0007144) |
| 0.0 | 0.1 | GO:1904526 | regulation of microtubule binding(GO:1904526) |
| 0.0 | 0.1 | GO:0001964 | startle response(GO:0001964) |
| 0.0 | 2.2 | GO:0051306 | mitotic sister chromatid separation(GO:0051306) |
| 0.0 | 0.7 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
| 0.0 | 0.2 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) |
| 0.0 | 0.5 | GO:1990034 | calcium ion export from cell(GO:1990034) |
| 0.0 | 0.6 | GO:0006903 | vesicle targeting(GO:0006903) |
| 0.0 | 0.4 | GO:0060148 | positive regulation of posttranscriptional gene silencing(GO:0060148) |
| 0.0 | 0.1 | GO:0031392 | regulation of prostaglandin biosynthetic process(GO:0031392) negative regulation of prostaglandin biosynthetic process(GO:0031393) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
| 0.0 | 0.2 | GO:0045793 | positive regulation of cell size(GO:0045793) |
| 0.0 | 0.1 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
| 0.0 | 0.7 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
| 0.0 | 1.0 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.0 | 1.0 | GO:0044458 | motile cilium assembly(GO:0044458) |
| 0.0 | 0.5 | GO:0046931 | pore complex assembly(GO:0046931) |
| 0.0 | 0.6 | GO:0007616 | long-term memory(GO:0007616) |
| 0.0 | 0.1 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
| 0.0 | 0.3 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
| 0.0 | 0.5 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
| 0.0 | 0.2 | GO:1903182 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 0.0 | 0.7 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
| 0.0 | 0.8 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
| 0.0 | 0.1 | GO:0032470 | regulation of twitch skeletal muscle contraction(GO:0014724) regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) positive regulation of endoplasmic reticulum calcium ion concentration(GO:0032470) maintenance of mitochondrion location(GO:0051659) |
| 0.0 | 0.2 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
| 0.0 | 0.5 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
| 0.0 | 0.6 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
| 0.0 | 0.2 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
| 0.0 | 0.2 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
| 0.0 | 0.5 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.0 | 0.4 | GO:0042921 | glucocorticoid receptor signaling pathway(GO:0042921) |
| 0.0 | 0.3 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
| 0.0 | 0.1 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
| 0.0 | 0.1 | GO:0035564 | regulation of kidney size(GO:0035564) |
| 0.0 | 0.3 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
| 0.0 | 0.1 | GO:0002934 | desmosome organization(GO:0002934) |
| 0.0 | 0.3 | GO:0048625 | myoblast fate commitment(GO:0048625) |
| 0.0 | 0.3 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.0 | 0.1 | GO:0035063 | nuclear speck organization(GO:0035063) |
| 0.0 | 1.5 | GO:0051205 | protein insertion into membrane(GO:0051205) |
| 0.0 | 0.1 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
| 0.0 | 0.2 | GO:0038092 | nodal signaling pathway(GO:0038092) |
| 0.0 | 0.4 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
| 0.0 | 0.2 | GO:0021511 | spinal cord patterning(GO:0021511) |
| 0.0 | 2.4 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
| 0.0 | 0.2 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
| 0.0 | 4.0 | GO:0090630 | activation of GTPase activity(GO:0090630) |
| 0.0 | 0.1 | GO:0042723 | thiamine-containing compound metabolic process(GO:0042723) |
| 0.0 | 0.9 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
| 0.0 | 0.1 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
| 0.0 | 0.1 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
| 0.0 | 0.3 | GO:0006265 | DNA topological change(GO:0006265) |
| 0.0 | 0.8 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.0 | 0.4 | GO:0040023 | establishment of nucleus localization(GO:0040023) |
| 0.0 | 1.3 | GO:0050913 | sensory perception of bitter taste(GO:0050913) |
| 0.0 | 0.6 | GO:0042255 | ribosome assembly(GO:0042255) |
| 0.0 | 0.2 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
| 0.0 | 0.1 | GO:0090289 | regulation of osteoclast proliferation(GO:0090289) |
| 0.0 | 0.4 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
| 0.0 | 0.2 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.0 | 0.2 | GO:0044245 | polysaccharide digestion(GO:0044245) |
| 0.0 | 1.2 | GO:0018345 | protein palmitoylation(GO:0018345) |
| 0.0 | 0.2 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
| 0.0 | 0.1 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
| 0.0 | 0.1 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
| 0.0 | 0.4 | GO:0055093 | response to hyperoxia(GO:0055093) |
| 0.0 | 0.2 | GO:0071027 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
| 0.0 | 0.3 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.0 | 0.1 | GO:0031645 | negative regulation of neurological system process(GO:0031645) |
| 0.0 | 0.3 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
| 0.0 | 0.1 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
| 0.0 | 0.2 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 0.0 | 0.9 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
| 0.0 | 0.1 | GO:0060037 | pharyngeal system development(GO:0060037) |
| 0.0 | 0.2 | GO:0044090 | positive regulation of vacuole organization(GO:0044090) |
| 0.0 | 0.0 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
| 0.0 | 0.3 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
| 0.0 | 0.3 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
| 0.0 | 1.4 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
| 0.0 | 0.1 | GO:0046108 | uridine metabolic process(GO:0046108) |
| 0.0 | 1.7 | GO:0030574 | collagen catabolic process(GO:0030574) |
| 0.0 | 0.1 | GO:0072718 | response to cisplatin(GO:0072718) |
| 0.0 | 0.8 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
| 0.0 | 0.1 | GO:0045792 | negative regulation of cell size(GO:0045792) |
| 0.0 | 0.1 | GO:0032455 | nerve growth factor processing(GO:0032455) |
| 0.0 | 1.1 | GO:0006968 | cellular defense response(GO:0006968) |
| 0.0 | 0.4 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.0 | 0.1 | GO:0033037 | polysaccharide localization(GO:0033037) |
| 0.0 | 0.1 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
| 0.0 | 0.3 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.0 | 0.1 | GO:1904970 | brush border assembly(GO:1904970) |
| 0.0 | 0.1 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 0.0 | 0.1 | GO:0006710 | androgen catabolic process(GO:0006710) |
| 0.0 | 0.1 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.0 | 0.2 | GO:0048478 | replication fork protection(GO:0048478) |
| 0.0 | 0.0 | GO:0001579 | medium-chain fatty acid transport(GO:0001579) |
| 0.0 | 0.1 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
| 0.0 | 0.2 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 0.0 | 0.0 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
| 0.0 | 0.1 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
| 0.0 | 0.1 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
| 0.0 | 0.1 | GO:0006408 | snRNA export from nucleus(GO:0006408) |
| 0.0 | 0.3 | GO:0097340 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) |
| 0.0 | 0.0 | GO:1904357 | negative regulation of telomere maintenance via telomere lengthening(GO:1904357) |
| 0.0 | 0.1 | GO:0002005 | angiotensin catabolic process in blood(GO:0002005) |
| 0.0 | 0.0 | GO:0034287 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
| 0.0 | 0.0 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
| 0.0 | 0.1 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
| 0.0 | 0.2 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
| 0.0 | 0.1 | GO:0043249 | erythrocyte maturation(GO:0043249) |
| 0.0 | 0.0 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 0.0 | 0.1 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 0.0 | 0.0 | GO:0060715 | syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
| 0.0 | 0.1 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.0 | 0.1 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
| 0.0 | 0.1 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
| 0.0 | 0.0 | GO:1904816 | regulation of protein localization to chromosome, telomeric region(GO:1904814) positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
| 0.0 | 0.1 | GO:0036116 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 0.0 | 0.2 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
| 0.0 | 0.1 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
| 0.0 | 0.3 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
| 0.0 | 0.0 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
| 0.0 | 0.0 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
| 0.0 | 0.0 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
| 0.0 | 0.0 | GO:1990776 | response to angiotensin(GO:1990776) |
| 0.0 | 0.0 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
| 0.0 | 0.3 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.0 | 0.0 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 0.0 | 0.0 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
| 0.0 | 0.0 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
| 0.0 | 0.2 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.0 | 0.0 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 0.0 | 0.0 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
| 0.0 | 0.1 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
| 0.0 | 0.0 | GO:0001842 | neural fold formation(GO:0001842) |
Gene overrepresentation in cellular component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.4 | 7.1 | GO:1990723 | cytoplasmic periphery of the nuclear pore complex(GO:1990723) |
| 2.4 | 18.8 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
| 2.3 | 16.2 | GO:0042825 | TAP complex(GO:0042825) |
| 2.0 | 6.1 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
| 2.0 | 8.0 | GO:0097229 | sperm end piece(GO:0097229) |
| 1.8 | 7.3 | GO:0008537 | proteasome activator complex(GO:0008537) |
| 1.8 | 5.3 | GO:0035525 | NF-kappaB p50/p65 complex(GO:0035525) |
| 1.5 | 12.2 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
| 1.5 | 6.0 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
| 1.4 | 15.9 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
| 1.3 | 12.0 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
| 1.3 | 3.9 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
| 1.3 | 1.3 | GO:0034665 | integrin alpha1-beta1 complex(GO:0034665) |
| 1.3 | 10.3 | GO:0097451 | glial limiting end-foot(GO:0097451) |
| 1.3 | 8.9 | GO:0005610 | laminin-5 complex(GO:0005610) |
| 1.1 | 3.4 | GO:0071065 | alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
| 1.1 | 3.2 | GO:0042565 | RNA nuclear export complex(GO:0042565) |
| 1.1 | 5.3 | GO:0045160 | myosin I complex(GO:0045160) |
| 1.0 | 1.0 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
| 1.0 | 5.9 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
| 0.9 | 10.3 | GO:0042612 | MHC class I protein complex(GO:0042612) |
| 0.9 | 0.9 | GO:0034681 | integrin alpha11-beta1 complex(GO:0034681) |
| 0.8 | 2.5 | GO:0016938 | kinesin I complex(GO:0016938) |
| 0.8 | 3.2 | GO:0097179 | protease inhibitor complex(GO:0097179) |
| 0.8 | 3.9 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
| 0.8 | 0.8 | GO:0097450 | astrocyte end-foot(GO:0097450) |
| 0.8 | 13.6 | GO:0035631 | CD40 receptor complex(GO:0035631) |
| 0.7 | 4.4 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
| 0.7 | 3.0 | GO:0035517 | PR-DUB complex(GO:0035517) |
| 0.7 | 0.7 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
| 0.7 | 2.7 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
| 0.7 | 13.2 | GO:0005861 | troponin complex(GO:0005861) |
| 0.7 | 2.6 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
| 0.6 | 9.7 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 0.6 | 2.5 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
| 0.6 | 1.9 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
| 0.6 | 1.9 | GO:0001674 | female germ cell nucleus(GO:0001674) |
| 0.6 | 2.5 | GO:1990742 | microvesicle(GO:1990742) |
| 0.6 | 3.1 | GO:0036502 | Derlin-1-VIMP complex(GO:0036502) |
| 0.6 | 10.3 | GO:0032059 | bleb(GO:0032059) |
| 0.6 | 3.0 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
| 0.6 | 6.6 | GO:0071438 | invadopodium membrane(GO:0071438) |
| 0.6 | 1.7 | GO:0097441 | basilar dendrite(GO:0097441) |
| 0.5 | 10.3 | GO:0000812 | Swr1 complex(GO:0000812) |
| 0.5 | 8.6 | GO:0005642 | annulate lamellae(GO:0005642) |
| 0.5 | 2.1 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
| 0.5 | 5.8 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
| 0.5 | 3.1 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
| 0.5 | 2.1 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
| 0.5 | 2.1 | GO:0043256 | laminin complex(GO:0043256) |
| 0.5 | 2.0 | GO:1990879 | CST complex(GO:1990879) |
| 0.5 | 0.5 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
| 0.5 | 2.4 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
| 0.5 | 3.2 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
| 0.4 | 2.2 | GO:0035339 | SPOTS complex(GO:0035339) |
| 0.4 | 4.8 | GO:0097208 | alveolar lamellar body(GO:0097208) |
| 0.4 | 6.1 | GO:0043083 | synaptic cleft(GO:0043083) |
| 0.4 | 4.8 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
| 0.4 | 3.5 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
| 0.4 | 2.1 | GO:0070826 | paraferritin complex(GO:0070826) |
| 0.4 | 0.4 | GO:0043203 | axon hillock(GO:0043203) |
| 0.4 | 1.2 | GO:0034753 | nuclear aryl hydrocarbon receptor complex(GO:0034753) |
| 0.4 | 4.0 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 0.4 | 5.5 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
| 0.4 | 2.3 | GO:0097149 | centralspindlin complex(GO:0097149) |
| 0.4 | 4.3 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
| 0.4 | 11.9 | GO:0031143 | pseudopodium(GO:0031143) |
| 0.4 | 0.8 | GO:1990423 | RZZ complex(GO:1990423) |
| 0.3 | 2.1 | GO:0071797 | LUBAC complex(GO:0071797) |
| 0.3 | 0.7 | GO:0032444 | activin responsive factor complex(GO:0032444) |
| 0.3 | 7.2 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
| 0.3 | 0.7 | GO:0060199 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
| 0.3 | 1.3 | GO:0008043 | intracellular ferritin complex(GO:0008043) ferritin complex(GO:0070288) |
| 0.3 | 2.0 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
| 0.3 | 3.6 | GO:0005638 | lamin filament(GO:0005638) |
| 0.3 | 1.3 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
| 0.3 | 1.3 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
| 0.3 | 3.5 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 0.3 | 2.9 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
| 0.3 | 2.2 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
| 0.3 | 1.0 | GO:0008623 | CHRAC(GO:0008623) |
| 0.3 | 3.8 | GO:0070449 | elongin complex(GO:0070449) |
| 0.3 | 1.0 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
| 0.3 | 0.3 | GO:0097449 | astrocyte projection(GO:0097449) |
| 0.3 | 5.0 | GO:0033391 | chromatoid body(GO:0033391) |
| 0.3 | 0.3 | GO:0030689 | Noc complex(GO:0030689) |
| 0.3 | 6.8 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.3 | 1.8 | GO:0070545 | PeBoW complex(GO:0070545) |
| 0.3 | 1.5 | GO:0035061 | interchromatin granule(GO:0035061) |
| 0.3 | 1.2 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
| 0.3 | 0.9 | GO:0060987 | lipid tube(GO:0060987) |
| 0.3 | 3.3 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
| 0.3 | 2.6 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
| 0.3 | 1.2 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
| 0.3 | 2.0 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
| 0.3 | 1.1 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
| 0.3 | 0.9 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
| 0.3 | 2.0 | GO:1990037 | Lewy body core(GO:1990037) |
| 0.3 | 1.1 | GO:0034457 | Mpp10 complex(GO:0034457) |
| 0.3 | 0.8 | GO:0034455 | t-UTP complex(GO:0034455) |
| 0.3 | 1.4 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
| 0.3 | 31.6 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.3 | 7.2 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
| 0.3 | 1.1 | GO:0097123 | cyclin A1-CDK2 complex(GO:0097123) |
| 0.3 | 0.8 | GO:0042589 | zymogen granule membrane(GO:0042589) |
| 0.3 | 7.0 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
| 0.3 | 0.8 | GO:0071817 | MMXD complex(GO:0071817) |
| 0.3 | 0.8 | GO:0016939 | kinesin II complex(GO:0016939) |
| 0.3 | 2.4 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
| 0.3 | 1.9 | GO:0036021 | endolysosome lumen(GO:0036021) |
| 0.3 | 0.8 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
| 0.3 | 1.3 | GO:1990031 | pinceau fiber(GO:1990031) |
| 0.3 | 0.8 | GO:0033597 | mitotic checkpoint complex(GO:0033597) bub1-bub3 complex(GO:1990298) |
| 0.3 | 0.8 | GO:1990716 | axonemal central apparatus(GO:1990716) |
| 0.3 | 0.8 | GO:0072687 | meiotic spindle(GO:0072687) |
| 0.3 | 3.4 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
| 0.3 | 1.5 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
| 0.3 | 7.4 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 0.3 | 6.9 | GO:0044453 | nuclear membrane part(GO:0044453) |
| 0.3 | 17.3 | GO:0015030 | Cajal body(GO:0015030) |
| 0.3 | 2.8 | GO:0030127 | COPII vesicle coat(GO:0030127) |
| 0.3 | 5.8 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
| 0.3 | 1.8 | GO:0097209 | epidermal lamellar body(GO:0097209) |
| 0.3 | 1.3 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
| 0.2 | 2.7 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
| 0.2 | 13.5 | GO:0030673 | axolemma(GO:0030673) |
| 0.2 | 1.0 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
| 0.2 | 2.9 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
| 0.2 | 0.2 | GO:0032584 | growth cone membrane(GO:0032584) |
| 0.2 | 0.7 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
| 0.2 | 1.0 | GO:0000811 | GINS complex(GO:0000811) |
| 0.2 | 0.7 | GO:0098855 | HCN channel complex(GO:0098855) |
| 0.2 | 1.4 | GO:0089701 | U2AF(GO:0089701) |
| 0.2 | 2.2 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
| 0.2 | 1.0 | GO:1990032 | climbing fiber(GO:0044301) parallel fiber(GO:1990032) |
| 0.2 | 0.5 | GO:0070695 | FHF complex(GO:0070695) |
| 0.2 | 3.0 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.2 | 0.5 | GO:0005899 | insulin receptor complex(GO:0005899) |
| 0.2 | 3.9 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.2 | 8.7 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
| 0.2 | 2.3 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
| 0.2 | 0.7 | GO:0043159 | acrosomal matrix(GO:0043159) |
| 0.2 | 1.3 | GO:0032010 | phagolysosome(GO:0032010) |
| 0.2 | 0.4 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
| 0.2 | 2.0 | GO:0031045 | dense core granule(GO:0031045) |
| 0.2 | 1.3 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 0.2 | 1.5 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 0.2 | 1.7 | GO:0032133 | chromosome passenger complex(GO:0032133) |
| 0.2 | 1.9 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
| 0.2 | 0.4 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
| 0.2 | 0.4 | GO:0001652 | granular component(GO:0001652) |
| 0.2 | 1.8 | GO:0031616 | spindle pole centrosome(GO:0031616) |
| 0.2 | 1.4 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.2 | 2.8 | GO:0005869 | dynactin complex(GO:0005869) |
| 0.2 | 0.8 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
| 0.2 | 2.7 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.2 | 0.4 | GO:0010370 | perinucleolar chromocenter(GO:0010370) |
| 0.2 | 3.5 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
| 0.2 | 1.9 | GO:0000322 | storage vacuole(GO:0000322) |
| 0.2 | 0.2 | GO:0097386 | glial cell projection(GO:0097386) |
| 0.2 | 0.6 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
| 0.2 | 2.6 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
| 0.2 | 14.2 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
| 0.2 | 0.9 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
| 0.2 | 0.7 | GO:0031905 | early endosome lumen(GO:0031905) |
| 0.2 | 1.5 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
| 0.2 | 5.4 | GO:0031258 | lamellipodium membrane(GO:0031258) |
| 0.2 | 1.8 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
| 0.2 | 0.9 | GO:0044754 | autolysosome(GO:0044754) |
| 0.2 | 2.9 | GO:0001520 | outer dense fiber(GO:0001520) |
| 0.2 | 0.7 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
| 0.2 | 3.2 | GO:0032040 | small-subunit processome(GO:0032040) |
| 0.2 | 0.5 | GO:0031085 | BLOC-3 complex(GO:0031085) |
| 0.2 | 2.6 | GO:0030897 | HOPS complex(GO:0030897) |
| 0.2 | 1.6 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
| 0.2 | 0.5 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
| 0.2 | 1.2 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
| 0.2 | 0.7 | GO:0005839 | proteasome core complex(GO:0005839) |
| 0.2 | 0.9 | GO:0044326 | dendritic spine neck(GO:0044326) |
| 0.2 | 1.0 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
| 0.2 | 10.5 | GO:0016235 | aggresome(GO:0016235) |
| 0.2 | 4.9 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
| 0.2 | 1.7 | GO:0061574 | ASAP complex(GO:0061574) |
| 0.2 | 1.0 | GO:0000788 | nuclear nucleosome(GO:0000788) |
| 0.2 | 1.0 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
| 0.2 | 0.8 | GO:0030061 | mitochondrial crista(GO:0030061) |
| 0.2 | 1.2 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
| 0.2 | 0.5 | GO:0005726 | perichromatin fibrils(GO:0005726) |
| 0.2 | 0.5 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
| 0.2 | 2.3 | GO:0033093 | Weibel-Palade body(GO:0033093) |
| 0.2 | 1.0 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
| 0.2 | 1.6 | GO:0030686 | 90S preribosome(GO:0030686) |
| 0.2 | 2.3 | GO:0016013 | syntrophin complex(GO:0016013) |
| 0.2 | 1.6 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.2 | 0.6 | GO:0000438 | core TFIIH complex portion of holo TFIIH complex(GO:0000438) |
| 0.2 | 0.6 | GO:0070876 | SOSS complex(GO:0070876) |
| 0.2 | 6.5 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
| 0.2 | 0.8 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
| 0.2 | 1.2 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
| 0.2 | 0.5 | GO:0097598 | sperm cytoplasmic droplet(GO:0097598) |
| 0.2 | 1.7 | GO:0097512 | cardiac myofibril(GO:0097512) |
| 0.2 | 0.5 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
| 0.1 | 0.4 | GO:0005745 | m-AAA complex(GO:0005745) |
| 0.1 | 0.4 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
| 0.1 | 0.6 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
| 0.1 | 4.2 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
| 0.1 | 1.3 | GO:0097524 | sperm plasma membrane(GO:0097524) |
| 0.1 | 1.2 | GO:0031415 | NatA complex(GO:0031415) |
| 0.1 | 0.1 | GO:0019815 | B cell receptor complex(GO:0019815) |
| 0.1 | 3.0 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
| 0.1 | 0.6 | GO:0000923 | equatorial microtubule organizing center(GO:0000923) |
| 0.1 | 2.2 | GO:0034709 | methylosome(GO:0034709) |
| 0.1 | 1.1 | GO:0030904 | retromer complex(GO:0030904) |
| 0.1 | 1.1 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.1 | 1.3 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
| 0.1 | 1.0 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
| 0.1 | 0.4 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
| 0.1 | 1.5 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
| 0.1 | 0.6 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
| 0.1 | 1.1 | GO:0016272 | prefoldin complex(GO:0016272) |
| 0.1 | 0.6 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
| 0.1 | 3.7 | GO:0044295 | axonal growth cone(GO:0044295) |
| 0.1 | 0.1 | GO:0034678 | integrin alpha8-beta1 complex(GO:0034678) |
| 0.1 | 2.9 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 0.1 | 1.3 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
| 0.1 | 1.3 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
| 0.1 | 0.7 | GO:0071942 | XPC complex(GO:0071942) |
| 0.1 | 0.7 | GO:0036019 | endolysosome(GO:0036019) |
| 0.1 | 34.3 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
| 0.1 | 0.7 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
| 0.1 | 3.2 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
| 0.1 | 0.4 | GO:0060187 | cell pole(GO:0060187) |
| 0.1 | 1.4 | GO:0031931 | TORC1 complex(GO:0031931) |
| 0.1 | 0.9 | GO:0044292 | dendrite terminus(GO:0044292) |
| 0.1 | 1.3 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
| 0.1 | 1.8 | GO:0001741 | XY body(GO:0001741) |
| 0.1 | 0.8 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
| 0.1 | 0.9 | GO:0000801 | central element(GO:0000801) |
| 0.1 | 0.6 | GO:0035841 | new growing cell tip(GO:0035841) |
| 0.1 | 0.5 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
| 0.1 | 0.8 | GO:0005883 | neurofilament(GO:0005883) |
| 0.1 | 0.5 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
| 0.1 | 1.5 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
| 0.1 | 0.2 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
| 0.1 | 0.4 | GO:0036398 | TCR signalosome(GO:0036398) |
| 0.1 | 0.4 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
| 0.1 | 11.8 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 0.1 | 0.6 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
| 0.1 | 1.4 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 0.1 | 0.4 | GO:0036284 | tubulobulbar complex(GO:0036284) |
| 0.1 | 2.8 | GO:0030056 | hemidesmosome(GO:0030056) |
| 0.1 | 2.9 | GO:0000791 | euchromatin(GO:0000791) |
| 0.1 | 9.1 | GO:0042734 | presynaptic membrane(GO:0042734) |
| 0.1 | 2.5 | GO:0005865 | striated muscle thin filament(GO:0005865) |
| 0.1 | 0.1 | GO:0002139 | stereocilia coupling link(GO:0002139) |
| 0.1 | 1.1 | GO:0000938 | GARP complex(GO:0000938) |
| 0.1 | 0.8 | GO:0032021 | NELF complex(GO:0032021) |
| 0.1 | 0.9 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 0.1 | 0.6 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
| 0.1 | 1.8 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
| 0.1 | 0.5 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
| 0.1 | 0.6 | GO:0071953 | elastic fiber(GO:0071953) |
| 0.1 | 5.5 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.1 | 4.1 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
| 0.1 | 2.2 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.1 | 0.9 | GO:1990130 | Iml1 complex(GO:1990130) |
| 0.1 | 1.0 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
| 0.1 | 0.3 | GO:0000229 | cytoplasmic chromosome(GO:0000229) |
| 0.1 | 0.3 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
| 0.1 | 0.6 | GO:0036449 | microtubule minus-end(GO:0036449) |
| 0.1 | 6.9 | GO:0055038 | recycling endosome membrane(GO:0055038) |
| 0.1 | 0.4 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
| 0.1 | 1.9 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
| 0.1 | 0.7 | GO:1990630 | IRE1-RACK1-PP2A complex(GO:1990630) |
| 0.1 | 1.3 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
| 0.1 | 0.7 | GO:0044327 | dendritic spine head(GO:0044327) |
| 0.1 | 0.4 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
| 0.1 | 0.3 | GO:0019031 | viral envelope(GO:0019031) viral membrane(GO:0036338) |
| 0.1 | 1.2 | GO:0061700 | Seh1-associated complex(GO:0035859) GATOR2 complex(GO:0061700) |
| 0.1 | 1.0 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
| 0.1 | 0.7 | GO:0097486 | multivesicular body lumen(GO:0097486) |
| 0.1 | 1.6 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 0.1 | 2.9 | GO:0002102 | podosome(GO:0002102) |
| 0.1 | 2.4 | GO:0002080 | acrosomal membrane(GO:0002080) |
| 0.1 | 3.1 | GO:0016234 | inclusion body(GO:0016234) |
| 0.1 | 3.2 | GO:0005776 | autophagosome(GO:0005776) |
| 0.1 | 1.2 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
| 0.1 | 0.2 | GO:0097636 | intrinsic component of autophagosome membrane(GO:0097636) integral component of autophagosome membrane(GO:0097637) |
| 0.1 | 0.6 | GO:0030891 | VCB complex(GO:0030891) |
| 0.1 | 0.7 | GO:0044305 | calyx of Held(GO:0044305) |
| 0.1 | 0.6 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
| 0.1 | 0.4 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 0.1 | 0.7 | GO:0032280 | symmetric synapse(GO:0032280) |
| 0.1 | 0.7 | GO:0019774 | proteasome core complex, beta-subunit complex(GO:0019774) |
| 0.1 | 2.3 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
| 0.1 | 0.2 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
| 0.1 | 2.2 | GO:0000242 | pericentriolar material(GO:0000242) |
| 0.1 | 0.9 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.1 | 5.8 | GO:0005876 | spindle microtubule(GO:0005876) |
| 0.1 | 0.7 | GO:0034688 | integrin alphaM-beta2 complex(GO:0034688) |
| 0.1 | 36.3 | GO:0031965 | nuclear membrane(GO:0031965) |
| 0.1 | 4.6 | GO:0034707 | chloride channel complex(GO:0034707) |
| 0.1 | 0.5 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
| 0.1 | 1.1 | GO:0071439 | clathrin complex(GO:0071439) |
| 0.1 | 14.0 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
| 0.1 | 0.4 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
| 0.1 | 0.8 | GO:0001739 | sex chromatin(GO:0001739) |
| 0.1 | 0.5 | GO:0005916 | fascia adherens(GO:0005916) |
| 0.1 | 4.1 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
| 0.1 | 0.7 | GO:0072487 | MSL complex(GO:0072487) |
| 0.1 | 16.4 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.1 | 1.1 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
| 0.1 | 0.5 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
| 0.1 | 0.4 | GO:0031523 | Myb complex(GO:0031523) |
| 0.1 | 1.6 | GO:0035371 | microtubule plus-end(GO:0035371) |
| 0.1 | 0.9 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.1 | 0.2 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
| 0.1 | 0.2 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
| 0.1 | 0.8 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
| 0.1 | 0.7 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
| 0.1 | 0.3 | GO:0005960 | glycine cleavage complex(GO:0005960) |
| 0.1 | 0.6 | GO:0033269 | internode region of axon(GO:0033269) |
| 0.1 | 0.1 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
| 0.1 | 0.6 | GO:0005579 | membrane attack complex(GO:0005579) |
| 0.1 | 0.3 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
| 0.1 | 7.3 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
| 0.1 | 11.3 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
| 0.1 | 0.6 | GO:0044194 | cytolytic granule(GO:0044194) |
| 0.1 | 1.6 | GO:0070822 | Sin3-type complex(GO:0070822) |
| 0.1 | 0.4 | GO:0070470 | plasma membrane respiratory chain(GO:0070470) |
| 0.1 | 1.9 | GO:0005771 | multivesicular body(GO:0005771) |
| 0.1 | 0.4 | GO:0060171 | stereocilium membrane(GO:0060171) |
| 0.1 | 0.2 | GO:0001534 | radial spoke(GO:0001534) |
| 0.1 | 22.6 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
| 0.1 | 0.8 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 0.1 | 0.2 | GO:0034515 | proteasome storage granule(GO:0034515) |
| 0.1 | 2.0 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 0.1 | 0.3 | GO:0097165 | nuclear stress granule(GO:0097165) |
| 0.1 | 1.2 | GO:0005682 | U5 snRNP(GO:0005682) |
| 0.1 | 6.3 | GO:1904813 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
| 0.1 | 7.0 | GO:0030496 | midbody(GO:0030496) |
| 0.1 | 0.3 | GO:0032437 | cuticular plate(GO:0032437) |
| 0.1 | 0.4 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
| 0.1 | 0.9 | GO:0038201 | TOR complex(GO:0038201) |
| 0.1 | 0.3 | GO:0042599 | lamellar body(GO:0042599) |
| 0.1 | 0.2 | GO:0033011 | perinuclear theca(GO:0033011) |
| 0.1 | 0.1 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
| 0.1 | 7.6 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
| 0.1 | 2.1 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
| 0.1 | 0.4 | GO:0060091 | kinocilium(GO:0060091) |
| 0.1 | 0.3 | GO:0008278 | cohesin complex(GO:0008278) |
| 0.1 | 1.3 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.1 | 2.1 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.1 | 0.2 | GO:0036156 | inner dynein arm(GO:0036156) |
| 0.1 | 0.2 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
| 0.1 | 0.7 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
| 0.1 | 0.2 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
| 0.1 | 0.2 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
| 0.1 | 0.3 | GO:0072534 | perineuronal net(GO:0072534) |
| 0.1 | 10.2 | GO:0070160 | occluding junction(GO:0070160) |
| 0.1 | 0.5 | GO:0070187 | telosome(GO:0070187) |
| 0.1 | 0.4 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
| 0.1 | 1.0 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
| 0.1 | 0.2 | GO:0070701 | mucus layer(GO:0070701) |
| 0.1 | 1.6 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
| 0.0 | 0.3 | GO:0005687 | U4 snRNP(GO:0005687) |
| 0.0 | 0.0 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
| 0.0 | 5.9 | GO:0044306 | neuron projection terminus(GO:0044306) |
| 0.0 | 1.1 | GO:0000145 | exocyst(GO:0000145) |
| 0.0 | 5.8 | GO:0032587 | ruffle membrane(GO:0032587) |
| 0.0 | 1.6 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
| 0.0 | 0.4 | GO:0030478 | actin cap(GO:0030478) |
| 0.0 | 3.1 | GO:0070821 | tertiary granule membrane(GO:0070821) |
| 0.0 | 0.5 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
| 0.0 | 0.3 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
| 0.0 | 0.2 | GO:1990356 | sumoylated E2 ligase complex(GO:1990356) |
| 0.0 | 1.2 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
| 0.0 | 3.6 | GO:0048475 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
| 0.0 | 0.1 | GO:0031084 | BLOC-2 complex(GO:0031084) |
| 0.0 | 0.1 | GO:0035370 | UBC13-UEV1A complex(GO:0035370) |
| 0.0 | 1.5 | GO:0072686 | mitotic spindle(GO:0072686) |
| 0.0 | 0.3 | GO:0071664 | beta-catenin-TCF7L2 complex(GO:0070369) catenin-TCF7L2 complex(GO:0071664) |
| 0.0 | 0.2 | GO:0044232 | organelle membrane contact site(GO:0044232) |
| 0.0 | 0.6 | GO:0005686 | U2 snRNP(GO:0005686) |
| 0.0 | 2.4 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
| 0.0 | 2.7 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
| 0.0 | 0.4 | GO:0097431 | mitotic spindle pole(GO:0097431) |
| 0.0 | 0.1 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
| 0.0 | 0.1 | GO:0098845 | postsynaptic endosome(GO:0098845) |
| 0.0 | 0.8 | GO:0035145 | exon-exon junction complex(GO:0035145) |
| 0.0 | 0.3 | GO:0031904 | endosome lumen(GO:0031904) |
| 0.0 | 3.1 | GO:0055037 | recycling endosome(GO:0055037) |
| 0.0 | 1.1 | GO:0031594 | neuromuscular junction(GO:0031594) |
| 0.0 | 56.3 | GO:0005615 | extracellular space(GO:0005615) |
| 0.0 | 1.0 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
| 0.0 | 0.3 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 0.0 | 0.1 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.0 | 22.1 | GO:0044431 | Golgi apparatus part(GO:0044431) |
| 0.0 | 0.4 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.0 | 0.1 | GO:0000243 | commitment complex(GO:0000243) |
| 0.0 | 0.9 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.0 | 0.3 | GO:0070852 | cell body fiber(GO:0070852) |
| 0.0 | 0.3 | GO:0030914 | STAGA complex(GO:0030914) |
| 0.0 | 2.0 | GO:0000118 | histone deacetylase complex(GO:0000118) |
| 0.0 | 0.4 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.0 | 0.0 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
| 0.0 | 0.2 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
| 0.0 | 0.2 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 0.0 | 0.7 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
| 0.0 | 0.0 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
| 0.0 | 0.2 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
| 0.0 | 0.6 | GO:0005761 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
| 0.0 | 0.1 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
| 0.0 | 0.0 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
| 0.0 | 0.1 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
| 0.0 | 0.1 | GO:0070847 | core mediator complex(GO:0070847) |
| 0.0 | 0.1 | GO:0036157 | outer dynein arm(GO:0036157) |
Gene overrepresentation in molecular function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.4 | 13.2 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
| 2.8 | 8.4 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
| 2.6 | 7.9 | GO:0004912 | interleukin-3 receptor activity(GO:0004912) |
| 2.5 | 2.5 | GO:0019957 | C-C chemokine binding(GO:0019957) |
| 2.3 | 21.0 | GO:0046978 | TAP binding(GO:0046977) TAP1 binding(GO:0046978) |
| 2.2 | 6.7 | GO:0042007 | interleukin-18 binding(GO:0042007) |
| 2.1 | 8.5 | GO:0008832 | dGTPase activity(GO:0008832) triphosphoric monoester hydrolase activity(GO:0016793) guanyl deoxyribonucleotide binding(GO:0032560) dGTP binding(GO:0032567) |
| 2.1 | 6.2 | GO:0042008 | interleukin-18 receptor activity(GO:0042008) |
| 2.0 | 6.1 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
| 2.0 | 12.1 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
| 1.9 | 19.4 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
| 1.8 | 5.4 | GO:0009032 | thymidine phosphorylase activity(GO:0009032) pyrimidine-nucleoside phosphorylase activity(GO:0016154) |
| 1.8 | 27.1 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
| 1.8 | 5.4 | GO:0005289 | high-affinity basic amino acid transmembrane transporter activity(GO:0005287) high-affinity arginine transmembrane transporter activity(GO:0005289) high-affinity lysine transmembrane transporter activity(GO:0005292) |
| 1.7 | 5.1 | GO:0004613 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
| 1.7 | 11.9 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
| 1.6 | 6.3 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
| 1.6 | 6.2 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
| 1.5 | 9.0 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
| 1.5 | 4.5 | GO:0035248 | alpha-1,4-N-acetylgalactosaminyltransferase activity(GO:0035248) |
| 1.4 | 4.3 | GO:0042947 | glucoside transmembrane transporter activity(GO:0042947) |
| 1.3 | 3.9 | GO:0070364 | mitochondrial light strand promoter anti-sense binding(GO:0070361) mitochondrial heavy strand promoter anti-sense binding(GO:0070362) mitochondrial heavy strand promoter sense binding(GO:0070364) |
| 1.3 | 3.8 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
| 1.3 | 3.8 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
| 1.3 | 7.5 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
| 1.2 | 6.2 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
| 1.2 | 4.7 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
| 1.2 | 9.3 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
| 1.1 | 8.8 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
| 1.1 | 21.9 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
| 1.1 | 13.9 | GO:0031014 | troponin T binding(GO:0031014) |
| 1.1 | 14.9 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
| 1.1 | 3.2 | GO:0090631 | pre-miRNA transporter activity(GO:0090631) |
| 1.0 | 4.2 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
| 1.0 | 8.2 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
| 1.0 | 3.0 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
| 1.0 | 2.9 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
| 1.0 | 17.6 | GO:0031996 | thioesterase binding(GO:0031996) |
| 1.0 | 2.9 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
| 0.9 | 9.1 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
| 0.9 | 9.7 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
| 0.9 | 3.5 | GO:0004360 | glutamine-fructose-6-phosphate transaminase (isomerizing) activity(GO:0004360) |
| 0.9 | 2.7 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.9 | 5.3 | GO:0005497 | androgen binding(GO:0005497) |
| 0.9 | 0.9 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
| 0.9 | 6.0 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
| 0.9 | 4.3 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
| 0.8 | 5.9 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
| 0.8 | 2.5 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
| 0.8 | 3.3 | GO:0002046 | opsin binding(GO:0002046) |
| 0.8 | 4.1 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
| 0.8 | 3.2 | GO:0008478 | pyridoxal kinase activity(GO:0008478) |
| 0.8 | 3.2 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 0.8 | 2.4 | GO:0031862 | prostanoid receptor binding(GO:0031862) |
| 0.8 | 3.8 | GO:0004882 | androgen receptor activity(GO:0004882) |
| 0.8 | 3.0 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
| 0.7 | 7.5 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
| 0.7 | 4.4 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
| 0.7 | 3.7 | GO:0004905 | type I interferon receptor activity(GO:0004905) |
| 0.7 | 6.5 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
| 0.7 | 20.7 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 0.7 | 2.1 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
| 0.7 | 2.1 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
| 0.7 | 0.7 | GO:0070411 | I-SMAD binding(GO:0070411) |
| 0.7 | 2.1 | GO:0001641 | group II metabotropic glutamate receptor activity(GO:0001641) |
| 0.7 | 4.7 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
| 0.7 | 11.4 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.7 | 2.0 | GO:0047315 | kynurenine-glyoxylate transaminase activity(GO:0047315) |
| 0.7 | 5.9 | GO:0038049 | transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) |
| 0.6 | 3.2 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
| 0.6 | 3.2 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
| 0.6 | 3.8 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
| 0.6 | 2.5 | GO:0005457 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
| 0.6 | 1.9 | GO:0031751 | D4 dopamine receptor binding(GO:0031751) |
| 0.6 | 5.6 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
| 0.6 | 3.6 | GO:0048030 | disaccharide binding(GO:0048030) |
| 0.6 | 3.6 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
| 0.6 | 1.8 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
| 0.6 | 2.4 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 0.6 | 2.4 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
| 0.6 | 3.5 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
| 0.6 | 2.3 | GO:0098770 | FBXO family protein binding(GO:0098770) |
| 0.6 | 5.9 | GO:0042301 | phosphate ion binding(GO:0042301) |
| 0.6 | 2.3 | GO:0097677 | STAT family protein binding(GO:0097677) |
| 0.6 | 4.7 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
| 0.6 | 2.3 | GO:0061714 | folic acid receptor activity(GO:0061714) |
| 0.6 | 2.3 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
| 0.6 | 3.9 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 0.6 | 6.7 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
| 0.6 | 1.7 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) cholesterol O-acyltransferase activity(GO:0034736) |
| 0.6 | 13.4 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
| 0.6 | 10.0 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
| 0.6 | 3.9 | GO:0015057 | thrombin receptor activity(GO:0015057) |
| 0.5 | 4.4 | GO:0004645 | phosphorylase activity(GO:0004645) |
| 0.5 | 1.6 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
| 0.5 | 1.1 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
| 0.5 | 2.1 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
| 0.5 | 1.6 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
| 0.5 | 3.1 | GO:0005330 | dopamine:sodium symporter activity(GO:0005330) |
| 0.5 | 1.6 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
| 0.5 | 20.3 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.5 | 5.6 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 0.5 | 4.0 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
| 0.5 | 1.5 | GO:0004056 | argininosuccinate lyase activity(GO:0004056) |
| 0.5 | 1.5 | GO:0004766 | spermidine synthase activity(GO:0004766) |
| 0.5 | 1.5 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
| 0.5 | 0.5 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
| 0.5 | 3.4 | GO:0017050 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
| 0.5 | 13.1 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
| 0.5 | 10.7 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
| 0.5 | 7.2 | GO:0042834 | peptidoglycan binding(GO:0042834) |
| 0.5 | 2.8 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
| 0.5 | 4.7 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
| 0.5 | 2.4 | GO:0030620 | U2 snRNA binding(GO:0030620) |
| 0.5 | 2.8 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
| 0.5 | 1.4 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
| 0.5 | 1.9 | GO:1901375 | acetylcholine transmembrane transporter activity(GO:0005277) acetate ester transmembrane transporter activity(GO:1901375) |
| 0.5 | 1.4 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
| 0.5 | 4.1 | GO:0048495 | Roundabout binding(GO:0048495) |
| 0.5 | 1.4 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
| 0.5 | 1.4 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
| 0.4 | 3.1 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
| 0.4 | 1.8 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
| 0.4 | 3.6 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
| 0.4 | 2.2 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
| 0.4 | 1.3 | GO:0080101 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
| 0.4 | 3.0 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
| 0.4 | 0.4 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
| 0.4 | 2.1 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
| 0.4 | 2.1 | GO:0015086 | cadmium ion transmembrane transporter activity(GO:0015086) cobalt ion transmembrane transporter activity(GO:0015087) lead ion transmembrane transporter activity(GO:0015094) ferrous iron uptake transmembrane transporter activity(GO:0015639) |
| 0.4 | 1.3 | GO:0102008 | cytosolic dipeptidase activity(GO:0102008) |
| 0.4 | 2.1 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
| 0.4 | 2.9 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
| 0.4 | 1.7 | GO:0031531 | thyrotropin-releasing hormone receptor binding(GO:0031531) |
| 0.4 | 2.1 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
| 0.4 | 2.5 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
| 0.4 | 3.3 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 0.4 | 2.0 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
| 0.4 | 1.6 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
| 0.4 | 2.0 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
| 0.4 | 4.4 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
| 0.4 | 4.0 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 0.4 | 5.2 | GO:0070324 | thyroid hormone binding(GO:0070324) |
| 0.4 | 1.6 | GO:0035939 | microsatellite binding(GO:0035939) |
| 0.4 | 1.6 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
| 0.4 | 2.0 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
| 0.4 | 4.3 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
| 0.4 | 8.9 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
| 0.4 | 1.2 | GO:0010348 | lithium:proton antiporter activity(GO:0010348) |
| 0.4 | 0.4 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
| 0.4 | 4.2 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
| 0.4 | 1.1 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
| 0.4 | 5.3 | GO:0008556 | sodium:potassium-exchanging ATPase activity(GO:0005391) potassium-transporting ATPase activity(GO:0008556) |
| 0.4 | 1.9 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
| 0.4 | 2.3 | GO:0016748 | succinyltransferase activity(GO:0016748) |
| 0.4 | 1.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
| 0.4 | 3.4 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
| 0.4 | 1.5 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
| 0.4 | 3.0 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
| 0.4 | 6.8 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
| 0.4 | 10.8 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
| 0.4 | 1.4 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
| 0.4 | 2.2 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
| 0.4 | 1.1 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
| 0.4 | 2.5 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
| 0.4 | 1.1 | GO:0090422 | thiamine pyrophosphate transporter activity(GO:0090422) |
| 0.4 | 1.1 | GO:0033265 | choline binding(GO:0033265) |
| 0.4 | 1.1 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
| 0.4 | 1.8 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
| 0.4 | 1.8 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
| 0.3 | 4.9 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
| 0.3 | 3.5 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
| 0.3 | 1.4 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
| 0.3 | 1.7 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
| 0.3 | 3.1 | GO:0008865 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
| 0.3 | 1.0 | GO:0033746 | histone demethylase activity (H3-R2 specific)(GO:0033746) histone demethylase activity (H4-R3 specific)(GO:0033749) peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
| 0.3 | 5.4 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
| 0.3 | 1.3 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
| 0.3 | 0.3 | GO:0047787 | delta4-3-oxosteroid 5beta-reductase activity(GO:0047787) |
| 0.3 | 1.7 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
| 0.3 | 2.3 | GO:0008142 | oxysterol binding(GO:0008142) |
| 0.3 | 1.6 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
| 0.3 | 1.3 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
| 0.3 | 1.6 | GO:0051120 | hepoxilin A3 synthase activity(GO:0051120) |
| 0.3 | 4.5 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
| 0.3 | 1.6 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
| 0.3 | 6.0 | GO:0009881 | photoreceptor activity(GO:0009881) |
| 0.3 | 4.1 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
| 0.3 | 5.0 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
| 0.3 | 0.9 | GO:0050571 | 1,5-anhydro-D-fructose reductase activity(GO:0050571) |
| 0.3 | 2.2 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
| 0.3 | 1.2 | GO:0052901 | polyamine oxidase activity(GO:0046592) spermine:oxygen oxidoreductase (spermidine-forming) activity(GO:0052901) |
| 0.3 | 1.9 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
| 0.3 | 1.5 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
| 0.3 | 5.5 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
| 0.3 | 0.3 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
| 0.3 | 1.5 | GO:0004473 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
| 0.3 | 1.5 | GO:0008969 | phosphohistidine phosphatase activity(GO:0008969) |
| 0.3 | 1.2 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
| 0.3 | 2.1 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
| 0.3 | 2.1 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 0.3 | 1.2 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
| 0.3 | 2.4 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
| 0.3 | 2.6 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
| 0.3 | 1.2 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
| 0.3 | 0.3 | GO:0008513 | secondary active organic cation transmembrane transporter activity(GO:0008513) |
| 0.3 | 7.8 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
| 0.3 | 0.3 | GO:0016419 | [acyl-carrier-protein] S-malonyltransferase activity(GO:0004314) S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
| 0.3 | 7.4 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
| 0.3 | 1.1 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
| 0.3 | 2.3 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
| 0.3 | 2.0 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
| 0.3 | 2.3 | GO:0005047 | signal recognition particle binding(GO:0005047) |
| 0.3 | 0.6 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
| 0.3 | 1.4 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
| 0.3 | 3.4 | GO:0038132 | neuregulin binding(GO:0038132) |
| 0.3 | 1.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
| 0.3 | 1.9 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
| 0.3 | 3.3 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
| 0.3 | 0.6 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
| 0.3 | 1.9 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
| 0.3 | 5.2 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.3 | 0.5 | GO:0005462 | UDP-N-acetylglucosamine transmembrane transporter activity(GO:0005462) |
| 0.3 | 1.4 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
| 0.3 | 3.5 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
| 0.3 | 0.5 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
| 0.3 | 2.2 | GO:0046870 | cadmium ion binding(GO:0046870) |
| 0.3 | 0.5 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
| 0.3 | 5.3 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
| 0.3 | 1.6 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
| 0.3 | 0.8 | GO:0001727 | lipid kinase activity(GO:0001727) |
| 0.3 | 0.8 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
| 0.3 | 3.2 | GO:0033691 | sialic acid binding(GO:0033691) |
| 0.3 | 1.1 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 0.3 | 0.8 | GO:0008457 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
| 0.3 | 1.3 | GO:0045499 | chemorepellent activity(GO:0045499) |
| 0.3 | 0.5 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
| 0.3 | 5.7 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
| 0.3 | 0.5 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
| 0.3 | 1.0 | GO:0005151 | interleukin-1, Type II receptor binding(GO:0005151) |
| 0.3 | 1.0 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
| 0.3 | 1.0 | GO:0032406 | MutLbeta complex binding(GO:0032406) MutSbeta complex binding(GO:0032408) |
| 0.3 | 2.3 | GO:0003909 | DNA ligase activity(GO:0003909) |
| 0.3 | 2.0 | GO:0030621 | U4 snRNA binding(GO:0030621) |
| 0.3 | 1.5 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
| 0.3 | 1.0 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
| 0.2 | 2.2 | GO:0030883 | lipid antigen binding(GO:0030882) endogenous lipid antigen binding(GO:0030883) exogenous lipid antigen binding(GO:0030884) |
| 0.2 | 1.0 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
| 0.2 | 2.2 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
| 0.2 | 11.0 | GO:0005109 | frizzled binding(GO:0005109) |
| 0.2 | 0.2 | GO:0070905 | serine binding(GO:0070905) |
| 0.2 | 1.2 | GO:0035473 | lipase binding(GO:0035473) |
| 0.2 | 1.0 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
| 0.2 | 2.2 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
| 0.2 | 0.7 | GO:0033699 | DNA 5'-adenosine monophosphate hydrolase activity(GO:0033699) |
| 0.2 | 4.8 | GO:0051400 | BH domain binding(GO:0051400) |
| 0.2 | 5.2 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
| 0.2 | 1.2 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
| 0.2 | 1.6 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 0.2 | 1.4 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
| 0.2 | 4.4 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
| 0.2 | 5.1 | GO:0042056 | chemoattractant activity(GO:0042056) |
| 0.2 | 0.7 | GO:0045118 | azole transporter activity(GO:0045118) |
| 0.2 | 2.3 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
| 0.2 | 1.4 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
| 0.2 | 5.3 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
| 0.2 | 1.8 | GO:0051373 | FATZ binding(GO:0051373) |
| 0.2 | 6.8 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
| 0.2 | 0.7 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
| 0.2 | 5.2 | GO:0015172 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
| 0.2 | 1.1 | GO:0005119 | smoothened binding(GO:0005119) |
| 0.2 | 1.1 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
| 0.2 | 1.1 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
| 0.2 | 2.7 | GO:0031543 | peptidyl-proline dioxygenase activity(GO:0031543) peptidyl-proline 4-dioxygenase activity(GO:0031545) |
| 0.2 | 0.2 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
| 0.2 | 0.4 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
| 0.2 | 0.9 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
| 0.2 | 0.7 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
| 0.2 | 14.0 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
| 0.2 | 0.4 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
| 0.2 | 1.5 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
| 0.2 | 0.9 | GO:0098988 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
| 0.2 | 0.9 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
| 0.2 | 0.7 | GO:0000247 | C-8 sterol isomerase activity(GO:0000247) |
| 0.2 | 0.2 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
| 0.2 | 2.2 | GO:0005536 | glucose binding(GO:0005536) |
| 0.2 | 0.7 | GO:0060001 | minus-end directed microfilament motor activity(GO:0060001) |
| 0.2 | 1.5 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
| 0.2 | 48.6 | GO:0005125 | cytokine activity(GO:0005125) |
| 0.2 | 0.7 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
| 0.2 | 2.2 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
| 0.2 | 1.5 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
| 0.2 | 1.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
| 0.2 | 0.4 | GO:0070039 | rRNA (guanosine-2'-O-)-methyltransferase activity(GO:0070039) |
| 0.2 | 1.5 | GO:0034046 | poly(G) binding(GO:0034046) |
| 0.2 | 5.1 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 0.2 | 5.3 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.2 | 7.4 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
| 0.2 | 1.1 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
| 0.2 | 0.6 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
| 0.2 | 0.6 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
| 0.2 | 3.1 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
| 0.2 | 2.0 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
| 0.2 | 1.0 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
| 0.2 | 0.4 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
| 0.2 | 1.0 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
| 0.2 | 2.0 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 0.2 | 1.4 | GO:0042289 | MHC class II protein binding(GO:0042289) |
| 0.2 | 1.6 | GO:0032190 | acrosin binding(GO:0032190) |
| 0.2 | 2.8 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
| 0.2 | 0.4 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
| 0.2 | 1.0 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
| 0.2 | 3.6 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
| 0.2 | 1.0 | GO:0031685 | adenosine receptor binding(GO:0031685) |
| 0.2 | 0.6 | GO:0008431 | vitamin E binding(GO:0008431) |
| 0.2 | 0.6 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
| 0.2 | 0.6 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
| 0.2 | 0.8 | GO:0016295 | oleoyl-[acyl-carrier-protein] hydrolase activity(GO:0004320) myristoyl-[acyl-carrier-protein] hydrolase activity(GO:0016295) palmitoyl-[acyl-carrier-protein] hydrolase activity(GO:0016296) acyl-[acyl-carrier-protein] hydrolase activity(GO:0016297) |
| 0.2 | 0.6 | GO:0052858 | peptidyl-lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0052858) |
| 0.2 | 1.1 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
| 0.2 | 2.4 | GO:0017160 | Ral GTPase binding(GO:0017160) |
| 0.2 | 0.8 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) |
| 0.2 | 2.4 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
| 0.2 | 0.9 | GO:0042806 | fucose binding(GO:0042806) |
| 0.2 | 2.6 | GO:0045295 | gamma-catenin binding(GO:0045295) |
| 0.2 | 1.3 | GO:0070513 | death domain binding(GO:0070513) |
| 0.2 | 0.7 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
| 0.2 | 4.6 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.2 | 1.5 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
| 0.2 | 4.6 | GO:0022840 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
| 0.2 | 2.0 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
| 0.2 | 1.3 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
| 0.2 | 0.9 | GO:0031433 | telethonin binding(GO:0031433) |
| 0.2 | 0.4 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
| 0.2 | 4.6 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
| 0.2 | 0.5 | GO:0008502 | melatonin receptor activity(GO:0008502) |
| 0.2 | 1.4 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
| 0.2 | 8.5 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 0.2 | 10.1 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
| 0.2 | 0.2 | GO:0004031 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
| 0.2 | 2.1 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
| 0.2 | 0.5 | GO:0070984 | SET domain binding(GO:0070984) |
| 0.2 | 1.6 | GO:0015288 | porin activity(GO:0015288) |
| 0.2 | 1.2 | GO:0016433 | rRNA (adenine) methyltransferase activity(GO:0016433) |
| 0.2 | 0.4 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
| 0.2 | 1.2 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
| 0.2 | 0.7 | GO:0004379 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
| 0.2 | 0.5 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
| 0.2 | 0.5 | GO:0031755 | endothelial differentiation G-protein coupled receptor binding(GO:0031753) Edg-2 lysophosphatidic acid receptor binding(GO:0031755) |
| 0.2 | 4.1 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
| 0.2 | 1.0 | GO:0004359 | glutaminase activity(GO:0004359) |
| 0.2 | 5.8 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
| 0.2 | 2.2 | GO:0004568 | chitinase activity(GO:0004568) |
| 0.2 | 0.7 | GO:0086020 | gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling(GO:0086020) |
| 0.2 | 0.3 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
| 0.2 | 1.7 | GO:0031386 | protein tag(GO:0031386) |
| 0.2 | 3.6 | GO:0070628 | proteasome binding(GO:0070628) |
| 0.2 | 0.3 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
| 0.2 | 0.5 | GO:0004963 | follicle-stimulating hormone receptor activity(GO:0004963) |
| 0.2 | 1.7 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
| 0.2 | 0.8 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
| 0.2 | 1.6 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
| 0.2 | 3.3 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
| 0.2 | 2.3 | GO:0003796 | lysozyme activity(GO:0003796) |
| 0.2 | 0.5 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
| 0.2 | 4.7 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.2 | 3.3 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.2 | 3.6 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
| 0.2 | 0.8 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
| 0.2 | 1.4 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
| 0.2 | 0.9 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
| 0.2 | 0.5 | GO:0035575 | histone demethylase activity (H4-K20 specific)(GO:0035575) |
| 0.2 | 2.2 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.2 | 2.0 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 0.2 | 3.1 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.2 | 0.5 | GO:0034584 | piRNA binding(GO:0034584) |
| 0.2 | 0.8 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
| 0.2 | 0.3 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
| 0.2 | 0.6 | GO:0030298 | receptor signaling protein tyrosine kinase activator activity(GO:0030298) |
| 0.2 | 23.6 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.2 | 0.3 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
| 0.2 | 0.9 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
| 0.1 | 0.9 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
| 0.1 | 0.4 | GO:0004662 | CAAX-protein geranylgeranyltransferase activity(GO:0004662) |
| 0.1 | 0.6 | GO:0005148 | prolactin receptor binding(GO:0005148) |
| 0.1 | 4.2 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
| 0.1 | 0.3 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
| 0.1 | 0.7 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 0.1 | 5.3 | GO:0070034 | telomerase RNA binding(GO:0070034) |
| 0.1 | 8.5 | GO:0031593 | polyubiquitin binding(GO:0031593) |
| 0.1 | 0.4 | GO:0045145 | single-stranded DNA 5'-3' exodeoxyribonuclease activity(GO:0045145) |
| 0.1 | 2.5 | GO:0016918 | retinal binding(GO:0016918) |
| 0.1 | 0.6 | GO:0004771 | sterol esterase activity(GO:0004771) |
| 0.1 | 0.3 | GO:0004998 | transferrin receptor activity(GO:0004998) |
| 0.1 | 0.4 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
| 0.1 | 0.6 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
| 0.1 | 4.0 | GO:0030515 | snoRNA binding(GO:0030515) |
| 0.1 | 0.6 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
| 0.1 | 0.3 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
| 0.1 | 1.1 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
| 0.1 | 0.4 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
| 0.1 | 0.4 | GO:1902271 | D3 vitamins binding(GO:1902271) |
| 0.1 | 0.7 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
| 0.1 | 1.0 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
| 0.1 | 0.6 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
| 0.1 | 3.0 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
| 0.1 | 0.4 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
| 0.1 | 1.9 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
| 0.1 | 0.7 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
| 0.1 | 1.2 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
| 0.1 | 5.7 | GO:0008536 | Ran GTPase binding(GO:0008536) |
| 0.1 | 1.3 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
| 0.1 | 1.5 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
| 0.1 | 0.9 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
| 0.1 | 0.1 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
| 0.1 | 3.4 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.1 | 2.5 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
| 0.1 | 2.7 | GO:0005344 | oxygen transporter activity(GO:0005344) |
| 0.1 | 3.3 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.1 | 1.2 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
| 0.1 | 1.1 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
| 0.1 | 54.2 | GO:0003924 | GTPase activity(GO:0003924) |
| 0.1 | 0.7 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.1 | 0.7 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
| 0.1 | 0.7 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
| 0.1 | 8.9 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
| 0.1 | 1.0 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
| 0.1 | 2.3 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
| 0.1 | 0.4 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
| 0.1 | 4.0 | GO:0042605 | peptide antigen binding(GO:0042605) |
| 0.1 | 0.1 | GO:0097604 | temperature-gated cation channel activity(GO:0097604) |
| 0.1 | 0.6 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
| 0.1 | 1.1 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
| 0.1 | 0.6 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
| 0.1 | 1.4 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
| 0.1 | 1.1 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
| 0.1 | 2.6 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
| 0.1 | 0.5 | GO:0004102 | choline O-acetyltransferase activity(GO:0004102) |
| 0.1 | 1.0 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
| 0.1 | 1.6 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
| 0.1 | 0.2 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 0.1 | 12.8 | GO:0017048 | Rho GTPase binding(GO:0017048) |
| 0.1 | 1.0 | GO:0000182 | rDNA binding(GO:0000182) |
| 0.1 | 1.7 | GO:1990459 | transferrin receptor binding(GO:1990459) |
| 0.1 | 1.2 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
| 0.1 | 8.9 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
| 0.1 | 3.1 | GO:0001968 | fibronectin binding(GO:0001968) |
| 0.1 | 1.4 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
| 0.1 | 2.6 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
| 0.1 | 0.3 | GO:0046923 | ER retention sequence binding(GO:0046923) |
| 0.1 | 0.7 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
| 0.1 | 0.7 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
| 0.1 | 1.9 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
| 0.1 | 0.6 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
| 0.1 | 1.4 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
| 0.1 | 1.1 | GO:0001851 | complement component C3b binding(GO:0001851) |
| 0.1 | 0.5 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
| 0.1 | 0.5 | GO:1902122 | chenodeoxycholic acid binding(GO:1902122) |
| 0.1 | 2.0 | GO:0032183 | SUMO binding(GO:0032183) |
| 0.1 | 0.4 | GO:0004341 | gluconolactonase activity(GO:0004341) |
| 0.1 | 1.0 | GO:0034056 | estrogen response element binding(GO:0034056) |
| 0.1 | 4.0 | GO:0005123 | death receptor binding(GO:0005123) |
| 0.1 | 0.4 | GO:0001156 | TFIIIC-class transcription factor binding(GO:0001156) |
| 0.1 | 0.7 | GO:0004122 | cystathionine beta-synthase activity(GO:0004122) |
| 0.1 | 1.0 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.1 | 0.8 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
| 0.1 | 1.0 | GO:0035174 | histone serine kinase activity(GO:0035174) |
| 0.1 | 0.3 | GO:0070259 | tyrosyl-DNA phosphodiesterase activity(GO:0070259) |
| 0.1 | 0.9 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
| 0.1 | 0.6 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
| 0.1 | 1.3 | GO:0004526 | ribonuclease P activity(GO:0004526) |
| 0.1 | 1.0 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
| 0.1 | 1.1 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
| 0.1 | 2.7 | GO:0019789 | SUMO transferase activity(GO:0019789) |
| 0.1 | 0.6 | GO:0045545 | syndecan binding(GO:0045545) |
| 0.1 | 2.0 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
| 0.1 | 0.4 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
| 0.1 | 1.7 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
| 0.1 | 0.5 | GO:0016531 | metallochaperone activity(GO:0016530) copper chaperone activity(GO:0016531) |
| 0.1 | 4.9 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
| 0.1 | 2.4 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.1 | 9.4 | GO:0005518 | collagen binding(GO:0005518) |
| 0.1 | 0.8 | GO:0030613 | oxidoreductase activity, acting on phosphorus or arsenic in donors(GO:0030613) oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor(GO:0030614) |
| 0.1 | 38.5 | GO:0005096 | GTPase activator activity(GO:0005096) |
| 0.1 | 0.5 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
| 0.1 | 1.1 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
| 0.1 | 0.3 | GO:0015218 | pyrimidine nucleotide transmembrane transporter activity(GO:0015218) |
| 0.1 | 0.4 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
| 0.1 | 1.5 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
| 0.1 | 0.3 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
| 0.1 | 2.1 | GO:0031005 | filamin binding(GO:0031005) |
| 0.1 | 0.4 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
| 0.1 | 0.3 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
| 0.1 | 0.9 | GO:0008469 | histone-arginine N-methyltransferase activity(GO:0008469) |
| 0.1 | 0.3 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
| 0.1 | 0.6 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
| 0.1 | 0.4 | GO:0099609 | microtubule lateral binding(GO:0099609) |
| 0.1 | 1.3 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
| 0.1 | 1.0 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.1 | 3.7 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
| 0.1 | 4.0 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.1 | 2.2 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
| 0.1 | 0.8 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
| 0.1 | 0.5 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
| 0.1 | 0.6 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
| 0.1 | 1.1 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
| 0.1 | 4.1 | GO:0005080 | protein kinase C binding(GO:0005080) |
| 0.1 | 0.3 | GO:0042781 | 3'-tRNA processing endoribonuclease activity(GO:0042781) |
| 0.1 | 1.0 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
| 0.1 | 0.3 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
| 0.1 | 0.5 | GO:0070728 | leucine binding(GO:0070728) |
| 0.1 | 2.0 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
| 0.1 | 0.1 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
| 0.1 | 0.4 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
| 0.1 | 0.4 | GO:0001855 | complement component C4b binding(GO:0001855) |
| 0.1 | 0.4 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
| 0.1 | 0.4 | GO:0008066 | glutamate receptor activity(GO:0008066) |
| 0.1 | 1.1 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 0.1 | 1.2 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
| 0.1 | 0.4 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
| 0.1 | 1.5 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
| 0.1 | 0.4 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
| 0.1 | 0.1 | GO:0002060 | purine nucleobase binding(GO:0002060) |
| 0.1 | 2.6 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
| 0.1 | 1.0 | GO:0034452 | dynactin binding(GO:0034452) |
| 0.1 | 0.3 | GO:0033842 | N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity(GO:0033842) |
| 0.1 | 3.8 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.1 | 0.3 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
| 0.1 | 0.2 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
| 0.1 | 0.5 | GO:0016015 | morphogen activity(GO:0016015) |
| 0.1 | 2.6 | GO:0004622 | lysophospholipase activity(GO:0004622) |
| 0.1 | 0.2 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
| 0.1 | 1.6 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
| 0.1 | 4.2 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
| 0.1 | 0.3 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
| 0.1 | 0.3 | GO:0031208 | POZ domain binding(GO:0031208) |
| 0.1 | 1.7 | GO:0030275 | LRR domain binding(GO:0030275) |
| 0.1 | 3.1 | GO:0000049 | tRNA binding(GO:0000049) |
| 0.1 | 0.2 | GO:0005350 | pyrimidine nucleobase transmembrane transporter activity(GO:0005350) pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
| 0.1 | 0.2 | GO:0004958 | prostaglandin F receptor activity(GO:0004958) |
| 0.1 | 0.3 | GO:0005042 | netrin receptor activity(GO:0005042) |
| 0.1 | 0.6 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
| 0.1 | 0.2 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
| 0.1 | 2.6 | GO:0030695 | GTPase regulator activity(GO:0030695) |
| 0.1 | 0.4 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
| 0.1 | 0.2 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
| 0.1 | 0.2 | GO:0098918 | structural constituent of synapse(GO:0098918) structural constituent of postsynaptic actin cytoskeleton(GO:0098973) |
| 0.1 | 1.3 | GO:0000150 | recombinase activity(GO:0000150) |
| 0.1 | 1.1 | GO:0019864 | IgG binding(GO:0019864) |
| 0.1 | 0.2 | GO:0070119 | interleukin-6 receptor activity(GO:0004915) interleukin-6 binding(GO:0019981) ciliary neurotrophic factor binding(GO:0070119) |
| 0.1 | 0.3 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) cholestenone 5-alpha-reductase activity(GO:0047751) |
| 0.1 | 0.1 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
| 0.1 | 0.4 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
| 0.1 | 0.3 | GO:0034618 | arginine binding(GO:0034618) |
| 0.1 | 0.2 | GO:0004878 | complement component C5a receptor activity(GO:0004878) |
| 0.1 | 0.2 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
| 0.1 | 0.6 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
| 0.1 | 0.4 | GO:0019003 | GDP binding(GO:0019003) |
| 0.1 | 0.2 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
| 0.1 | 0.4 | GO:0036033 | mediator complex binding(GO:0036033) |
| 0.1 | 0.6 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 0.1 | 3.5 | GO:0004385 | guanylate kinase activity(GO:0004385) |
| 0.1 | 0.2 | GO:0004418 | hydroxymethylbilane synthase activity(GO:0004418) |
| 0.1 | 0.1 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) alpha2-adrenergic receptor activity(GO:0004938) |
| 0.1 | 0.6 | GO:0070410 | co-SMAD binding(GO:0070410) |
| 0.1 | 1.6 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
| 0.1 | 0.5 | GO:0017069 | snRNA binding(GO:0017069) |
| 0.1 | 0.3 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
| 0.1 | 0.4 | GO:0042835 | BRE binding(GO:0042835) |
| 0.1 | 0.2 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
| 0.1 | 5.6 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
| 0.1 | 2.0 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
| 0.1 | 1.4 | GO:0008301 | DNA binding, bending(GO:0008301) |
| 0.1 | 0.3 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
| 0.1 | 2.3 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 0.1 | 0.7 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
| 0.1 | 2.1 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
| 0.1 | 2.3 | GO:0004629 | phospholipase C activity(GO:0004629) |
| 0.1 | 2.4 | GO:0030331 | estrogen receptor binding(GO:0030331) |
| 0.1 | 0.5 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
| 0.1 | 0.2 | GO:0050146 | nucleoside phosphotransferase activity(GO:0050146) |
| 0.1 | 0.3 | GO:0001515 | opioid peptide activity(GO:0001515) |
| 0.1 | 0.6 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
| 0.1 | 1.6 | GO:0030506 | ankyrin binding(GO:0030506) |
| 0.1 | 0.3 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
| 0.1 | 0.3 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
| 0.1 | 0.4 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 0.1 | 2.4 | GO:0030371 | translation repressor activity(GO:0030371) |
| 0.1 | 0.3 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
| 0.1 | 0.3 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
| 0.1 | 0.6 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
| 0.1 | 0.6 | GO:0008517 | folic acid transporter activity(GO:0008517) |
| 0.1 | 0.2 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
| 0.1 | 1.0 | GO:0004890 | GABA-A receptor activity(GO:0004890) GABA receptor activity(GO:0016917) |
| 0.1 | 0.4 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
| 0.1 | 0.2 | GO:0043813 | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity(GO:0043813) |
| 0.1 | 0.1 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
| 0.1 | 4.0 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) |
| 0.1 | 0.7 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
| 0.1 | 0.4 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
| 0.1 | 2.1 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.1 | 0.8 | GO:0001222 | transcription corepressor binding(GO:0001222) |
| 0.1 | 0.2 | GO:0052840 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
| 0.1 | 0.2 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
| 0.1 | 0.6 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
| 0.1 | 0.5 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
| 0.1 | 1.4 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
| 0.1 | 0.3 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
| 0.1 | 0.9 | GO:0004065 | arylsulfatase activity(GO:0004065) |
| 0.1 | 0.2 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
| 0.1 | 0.2 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
| 0.1 | 0.9 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
| 0.1 | 0.8 | GO:0010181 | FMN binding(GO:0010181) |
| 0.1 | 0.2 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
| 0.1 | 0.2 | GO:0034603 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
| 0.1 | 0.3 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
| 0.1 | 0.2 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
| 0.1 | 2.7 | GO:0005254 | chloride channel activity(GO:0005254) |
| 0.1 | 0.1 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
| 0.1 | 0.9 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
| 0.1 | 3.5 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
| 0.1 | 0.5 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
| 0.1 | 0.2 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
| 0.1 | 1.6 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
| 0.1 | 2.0 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 0.1 | 0.4 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
| 0.1 | 0.4 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
| 0.1 | 0.2 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
| 0.1 | 0.2 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 0.1 | 1.6 | GO:0070717 | poly-purine tract binding(GO:0070717) |
| 0.1 | 0.3 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
| 0.0 | 1.5 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
| 0.0 | 0.1 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
| 0.0 | 0.2 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
| 0.0 | 0.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
| 0.0 | 0.1 | GO:0019956 | chemokine binding(GO:0019956) |
| 0.0 | 12.0 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 0.0 | 0.4 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
| 0.0 | 0.5 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
| 0.0 | 0.1 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
| 0.0 | 0.2 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
| 0.0 | 0.4 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
| 0.0 | 0.1 | GO:0004803 | transposase activity(GO:0004803) |
| 0.0 | 1.2 | GO:0008527 | taste receptor activity(GO:0008527) |
| 0.0 | 0.1 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
| 0.0 | 0.7 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
| 0.0 | 0.1 | GO:0031696 | alpha-2C adrenergic receptor binding(GO:0031696) |
| 0.0 | 0.2 | GO:0019863 | IgE binding(GO:0019863) |
| 0.0 | 1.1 | GO:0008242 | omega peptidase activity(GO:0008242) |
| 0.0 | 0.2 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 0.0 | 0.3 | GO:0000146 | microfilament motor activity(GO:0000146) |
| 0.0 | 0.1 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
| 0.0 | 3.2 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
| 0.0 | 0.2 | GO:0004630 | phospholipase D activity(GO:0004630) |
| 0.0 | 0.3 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
| 0.0 | 0.0 | GO:0002054 | nucleobase binding(GO:0002054) |
| 0.0 | 0.2 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
| 0.0 | 0.9 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
| 0.0 | 0.2 | GO:0019534 | toxin transporter activity(GO:0019534) |
| 0.0 | 0.6 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
| 0.0 | 0.2 | GO:0046997 | oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
| 0.0 | 0.3 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
| 0.0 | 0.2 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 0.0 | 0.2 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
| 0.0 | 0.5 | GO:0004707 | MAP kinase activity(GO:0004707) |
| 0.0 | 0.2 | GO:0004875 | complement receptor activity(GO:0004875) |
| 0.0 | 0.8 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.0 | 0.5 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
| 0.0 | 0.2 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
| 0.0 | 0.6 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
| 0.0 | 0.1 | GO:0004087 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
| 0.0 | 0.2 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
| 0.0 | 0.9 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
| 0.0 | 0.4 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 0.0 | 0.1 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
| 0.0 | 3.4 | GO:0005267 | potassium channel activity(GO:0005267) |
| 0.0 | 0.1 | GO:0019865 | immunoglobulin binding(GO:0019865) |
| 0.0 | 0.4 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
| 0.0 | 0.0 | GO:0070878 | primary miRNA binding(GO:0070878) |
| 0.0 | 1.7 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.0 | 0.3 | GO:0008097 | 5S rRNA binding(GO:0008097) |
| 0.0 | 0.0 | GO:0003724 | RNA helicase activity(GO:0003724) |
| 0.0 | 0.2 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
| 0.0 | 2.8 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
| 0.0 | 0.1 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
| 0.0 | 0.3 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 0.0 | 0.1 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
| 0.0 | 0.1 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
| 0.0 | 0.1 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
| 0.0 | 0.1 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
| 0.0 | 6.0 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
| 0.0 | 0.3 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
| 0.0 | 0.1 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
| 0.0 | 0.5 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
| 0.0 | 0.1 | GO:1902444 | riboflavin binding(GO:1902444) |
| 0.0 | 0.1 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
| 0.0 | 0.3 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
| 0.0 | 0.2 | GO:0098821 | BMP receptor activity(GO:0098821) |
| 0.0 | 0.0 | GO:0015116 | sulfate transmembrane transporter activity(GO:0015116) |
| 0.0 | 4.0 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
| 0.0 | 0.1 | GO:0016936 | galactoside binding(GO:0016936) |
| 0.0 | 0.0 | GO:0043394 | proteoglycan binding(GO:0043394) |
| 0.0 | 2.3 | GO:0017137 | Rab GTPase binding(GO:0017137) |
| 0.0 | 0.2 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
| 0.0 | 0.3 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
| 0.0 | 0.1 | GO:0023024 | MHC class I protein complex binding(GO:0023024) |
| 0.0 | 0.2 | GO:0032051 | clathrin light chain binding(GO:0032051) |
| 0.0 | 0.2 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
| 0.0 | 0.1 | GO:0004925 | prolactin receptor activity(GO:0004925) |
| 0.0 | 1.8 | GO:0004896 | cytokine receptor activity(GO:0004896) |
| 0.0 | 1.4 | GO:0070888 | E-box binding(GO:0070888) |
| 0.0 | 0.2 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
| 0.0 | 0.0 | GO:0070404 | NADH binding(GO:0070404) |
| 0.0 | 0.2 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
| 0.0 | 0.1 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
| 0.0 | 0.1 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
| 0.0 | 0.1 | GO:0033857 | diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) |
| 0.0 | 0.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
| 0.0 | 0.2 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
| 0.0 | 0.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
| 0.0 | 1.5 | GO:0044325 | ion channel binding(GO:0044325) |
| 0.0 | 0.1 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 0.0 | 0.3 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
| 0.0 | 0.0 | GO:0004750 | ribulose-phosphate 3-epimerase activity(GO:0004750) |
| 0.0 | 0.2 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
| 0.0 | 0.0 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
| 0.0 | 0.4 | GO:0001671 | ATPase activator activity(GO:0001671) |
| 0.0 | 0.1 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
| 0.0 | 0.7 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
| 0.0 | 0.0 | GO:0016503 | pheromone receptor activity(GO:0016503) |
| 0.0 | 0.0 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
| 0.0 | 0.0 | GO:0070051 | fibrinogen binding(GO:0070051) |
| 0.0 | 0.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
| 0.0 | 0.3 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.7 | 37.2 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
| 0.7 | 2.9 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
| 0.7 | 12.4 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 0.6 | 14.3 | PID IL5 PATHWAY | IL5-mediated signaling events |
| 0.6 | 7.9 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
| 0.5 | 32.9 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
| 0.5 | 14.0 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.5 | 1.0 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 0.5 | 17.7 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 0.5 | 2.4 | PID IL3 PATHWAY | IL3-mediated signaling events |
| 0.4 | 9.3 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
| 0.4 | 1.3 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
| 0.4 | 4.2 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
| 0.4 | 14.9 | PID IL1 PATHWAY | IL1-mediated signaling events |
| 0.4 | 11.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 0.4 | 11.6 | PID ARF 3PATHWAY | Arf1 pathway |
| 0.4 | 6.2 | PID CD40 PATHWAY | CD40/CD40L signaling |
| 0.4 | 19.3 | ST G ALPHA I PATHWAY | G alpha i Pathway |
| 0.4 | 3.3 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
| 0.4 | 0.7 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
| 0.4 | 12.8 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
| 0.3 | 4.5 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
| 0.3 | 3.0 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
| 0.3 | 23.4 | PID FOXO PATHWAY | FoxO family signaling |
| 0.3 | 4.0 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
| 0.3 | 2.6 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.3 | 17.3 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 0.3 | 11.6 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
| 0.3 | 1.0 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
| 0.2 | 0.2 | SIG CHEMOTAXIS | Genes related to chemotaxis |
| 0.2 | 2.2 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.2 | 18.1 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
| 0.2 | 2.6 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
| 0.2 | 4.2 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.2 | 1.7 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
| 0.2 | 14.8 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
| 0.2 | 7.8 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 0.2 | 0.9 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
| 0.2 | 7.5 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
| 0.2 | 4.5 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 0.2 | 9.0 | PID RHOA PATHWAY | RhoA signaling pathway |
| 0.2 | 5.7 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.2 | 0.4 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
| 0.2 | 9.7 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
| 0.2 | 12.5 | PID LKB1 PATHWAY | LKB1 signaling events |
| 0.2 | 84.4 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
| 0.2 | 3.3 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
| 0.2 | 11.2 | PID AURORA B PATHWAY | Aurora B signaling |
| 0.2 | 2.9 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
| 0.2 | 10.9 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
| 0.2 | 2.0 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
| 0.2 | 3.7 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.2 | 3.6 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
| 0.2 | 0.5 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
| 0.2 | 4.6 | PID AURORA A PATHWAY | Aurora A signaling |
| 0.2 | 0.8 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.2 | 5.8 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
| 0.2 | 4.5 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.2 | 4.1 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.2 | 2.5 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 0.2 | 3.5 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
| 0.2 | 0.6 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
| 0.2 | 4.6 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 0.2 | 0.3 | PID IFNG PATHWAY | IFN-gamma pathway |
| 0.1 | 1.3 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
| 0.1 | 3.6 | PID NECTIN PATHWAY | Nectin adhesion pathway |
| 0.1 | 0.5 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
| 0.1 | 1.0 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
| 0.1 | 6.5 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 0.1 | 1.6 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
| 0.1 | 1.3 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
| 0.1 | 0.2 | PID ALK2 PATHWAY | ALK2 signaling events |
| 0.1 | 2.5 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
| 0.1 | 1.6 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
| 0.1 | 1.2 | PID MYC PATHWAY | C-MYC pathway |
| 0.1 | 6.5 | NABA COLLAGENS | Genes encoding collagen proteins |
| 0.1 | 1.3 | PID REELIN PATHWAY | Reelin signaling pathway |
| 0.1 | 1.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.1 | 3.0 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
| 0.1 | 2.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
| 0.1 | 4.4 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.1 | 18.7 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.1 | 22.3 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.1 | 7.5 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
| 0.1 | 3.2 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
| 0.1 | 10.2 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
| 0.1 | 0.6 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
| 0.1 | 1.3 | ST GA12 PATHWAY | G alpha 12 Pathway |
| 0.1 | 1.0 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
| 0.1 | 3.0 | PID ATR PATHWAY | ATR signaling pathway |
| 0.1 | 2.0 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
| 0.1 | 0.8 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
| 0.1 | 0.3 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
| 0.1 | 0.3 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
| 0.1 | 0.9 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
| 0.1 | 0.7 | PID EPHA FWDPATHWAY | EPHA forward signaling |
| 0.0 | 0.2 | PID TRAIL PATHWAY | TRAIL signaling pathway |
| 0.0 | 1.2 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
| 0.0 | 0.2 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
| 0.0 | 0.8 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
| 0.0 | 0.4 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
| 0.0 | 1.8 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
| 0.0 | 0.3 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
| 0.0 | 0.2 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
| 0.0 | 0.4 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.0 | 0.6 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
| 0.0 | 1.4 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
| 0.0 | 1.1 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 0.0 | 1.0 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
| 0.0 | 0.5 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
| 0.0 | 0.1 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
| 0.0 | 0.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
| 0.0 | 1.2 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.3 | 13.8 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
| 1.0 | 111.4 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 1.0 | 18.5 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
| 0.9 | 16.2 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
| 0.9 | 0.9 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
| 0.9 | 0.9 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
| 0.7 | 26.2 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.7 | 10.9 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
| 0.6 | 41.9 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
| 0.6 | 6.8 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.6 | 13.5 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
| 0.5 | 11.9 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
| 0.5 | 5.2 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
| 0.5 | 16.5 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
| 0.5 | 15.4 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
| 0.5 | 16.9 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
| 0.4 | 11.4 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
| 0.4 | 27.9 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
| 0.4 | 40.5 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
| 0.4 | 9.7 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 0.4 | 18.8 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
| 0.4 | 5.1 | REACTOME OPSINS | Genes involved in Opsins |
| 0.4 | 13.2 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
| 0.4 | 2.5 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
| 0.3 | 10.6 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
| 0.3 | 17.3 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
| 0.3 | 13.7 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
| 0.3 | 5.7 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
| 0.3 | 6.0 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
| 0.3 | 0.3 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
| 0.3 | 5.7 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
| 0.3 | 15.3 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
| 0.3 | 7.9 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.3 | 5.2 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 0.3 | 3.0 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
| 0.3 | 0.6 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
| 0.3 | 5.8 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
| 0.3 | 0.3 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
| 0.3 | 6.3 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
| 0.3 | 2.7 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 0.3 | 5.7 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
| 0.3 | 4.5 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
| 0.3 | 2.4 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.2 | 0.5 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
| 0.2 | 6.1 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
| 0.2 | 5.8 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
| 0.2 | 7.0 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.2 | 8.8 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
| 0.2 | 11.3 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
| 0.2 | 9.2 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 0.2 | 10.5 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
| 0.2 | 3.9 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
| 0.2 | 4.1 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
| 0.2 | 7.2 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
| 0.2 | 3.5 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
| 0.2 | 9.3 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 0.2 | 2.1 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
| 0.2 | 1.1 | REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION | Genes involved in Cleavage of Growing Transcript in the Termination Region |
| 0.2 | 0.4 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
| 0.2 | 4.7 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
| 0.2 | 4.7 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.2 | 7.4 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
| 0.2 | 0.7 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
| 0.2 | 0.7 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
| 0.2 | 3.5 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
| 0.2 | 9.4 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
| 0.2 | 4.0 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
| 0.2 | 3.3 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
| 0.2 | 1.2 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
| 0.2 | 1.2 | REACTOME METABOLISM OF MRNA | Genes involved in Metabolism of mRNA |
| 0.2 | 4.6 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
| 0.2 | 0.3 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
| 0.2 | 7.3 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
| 0.2 | 2.4 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
| 0.2 | 9.6 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
| 0.2 | 1.6 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
| 0.2 | 1.1 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
| 0.2 | 2.2 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
| 0.2 | 5.1 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
| 0.2 | 24.3 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
| 0.2 | 3.2 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
| 0.1 | 2.2 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
| 0.1 | 5.1 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
| 0.1 | 2.4 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
| 0.1 | 7.0 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
| 0.1 | 2.4 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
| 0.1 | 2.7 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
| 0.1 | 3.5 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
| 0.1 | 2.8 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
| 0.1 | 0.3 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
| 0.1 | 8.2 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
| 0.1 | 6.3 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
| 0.1 | 7.3 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.1 | 3.3 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
| 0.1 | 1.1 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS | Genes involved in CREB phosphorylation through the activation of Ras |
| 0.1 | 1.2 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
| 0.1 | 1.5 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
| 0.1 | 0.6 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
| 0.1 | 1.9 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.1 | 1.2 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
| 0.1 | 11.3 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
| 0.1 | 9.2 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
| 0.1 | 1.2 | REACTOME EARLY PHASE OF HIV LIFE CYCLE | Genes involved in Early Phase of HIV Life Cycle |
| 0.1 | 2.7 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
| 0.1 | 1.9 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
| 0.1 | 3.1 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
| 0.1 | 2.2 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
| 0.1 | 2.5 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
| 0.1 | 1.5 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
| 0.1 | 2.0 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
| 0.1 | 8.5 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.1 | 4.4 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
| 0.1 | 16.9 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
| 0.1 | 0.4 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
| 0.1 | 0.6 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
| 0.1 | 1.1 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
| 0.1 | 3.8 | REACTOME G1 PHASE | Genes involved in G1 Phase |
| 0.1 | 0.8 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
| 0.1 | 1.9 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
| 0.1 | 0.5 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
| 0.1 | 0.5 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
| 0.1 | 0.2 | REACTOME CELL CELL COMMUNICATION | Genes involved in Cell-Cell communication |
| 0.1 | 2.1 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.1 | 0.5 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
| 0.1 | 1.7 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
| 0.1 | 1.6 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
| 0.1 | 1.2 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
| 0.1 | 3.1 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
| 0.1 | 12.4 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
| 0.1 | 1.2 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.1 | 0.9 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
| 0.1 | 3.3 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.1 | 1.0 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
| 0.1 | 2.8 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
| 0.1 | 0.7 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
| 0.1 | 0.1 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
| 0.1 | 1.6 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
| 0.1 | 1.9 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.1 | 1.3 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 0.1 | 1.9 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
| 0.1 | 0.6 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
| 0.1 | 0.6 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
| 0.1 | 0.9 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
| 0.1 | 0.7 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
| 0.0 | 1.0 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
| 0.0 | 1.5 | REACTOME PI METABOLISM | Genes involved in PI Metabolism |
| 0.0 | 0.8 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
| 0.0 | 0.2 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 0.0 | 4.9 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
| 0.0 | 1.0 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
| 0.0 | 0.8 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.0 | 0.8 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
| 0.0 | 1.5 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
| 0.0 | 0.4 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| 0.0 | 0.7 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.0 | 0.4 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
| 0.0 | 0.4 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
| 0.0 | 0.2 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
| 0.0 | 0.6 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
| 0.0 | 2.9 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
| 0.0 | 0.4 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
| 0.0 | 0.2 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
| 0.0 | 0.3 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
| 0.0 | 1.3 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
| 0.0 | 2.1 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
| 0.0 | 0.9 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.0 | 0.2 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
| 0.0 | 3.2 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
| 0.0 | 0.2 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
| 0.0 | 0.1 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
| 0.0 | 0.4 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
| 0.0 | 3.1 | REACTOME CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | Genes involved in Class I MHC mediated antigen processing & presentation |
| 0.0 | 0.4 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
| 0.0 | 0.4 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
| 0.0 | 0.0 | REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS | Genes involved in Activation of NMDA receptor upon glutamate binding and postsynaptic events |
| 0.0 | 0.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
| 0.0 | 0.3 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
| 0.0 | 0.1 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
| 0.0 | 1.1 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |